<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Sci Rep</journal-id><journal-id journal-id-type="iso-abbrev">Sci Rep</journal-id><journal-id journal-id-type="pmc-domain-id">1579</journal-id><journal-id journal-id-type="pmc-domain">scirep</journal-id><journal-title-group><journal-title>Scientific Reports</journal-title></journal-title-group><issn pub-type="epub">2045-2322</issn><publisher><publisher-name>Nature Publishing Group</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11470146</article-id><article-id pub-id-type="pmcid-ver">PMC11470146.1</article-id><article-id pub-id-type="pmcaid">11470146</article-id><article-id pub-id-type="pmcaiid">11470146</article-id><article-id pub-id-type="pmid">39394390</article-id><article-id pub-id-type="doi">10.1038/s41598-024-74817-3</article-id><article-id pub-id-type="publisher-id">74817</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Tramadol use and incident dementia in older adults with musculoskeletal pain: a population-based retrospective cohort study</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Oh</surname><given-names initials="SN">Si Nae</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kim</surname><given-names initials="HJ">Hye Jun</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Shim</surname><given-names initials="JY">Jae Yong</given-names></name><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kim</surname><given-names initials="K">Kyuwoong</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Jeong</surname><given-names initials="S">Seogsong</given-names></name><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Park</surname><given-names initials="SJ">Sun Jae</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Lee</surname><given-names initials="SH">Sang Hyun</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ha</surname><given-names initials="JW">Joong Won</given-names></name><xref ref-type="aff" rid="Aff7">7</xref></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Park</surname><given-names initials="SM">Sang Min</given-names></name><address><email>smpark.snuh@gmail.com</email></address><xref ref-type="aff" rid="Aff3">3</xref><xref ref-type="aff" rid="Aff8">8</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/03c8k9q07</institution-id><institution-id institution-id-type="GRID">grid.416665.6</institution-id><institution-id institution-id-type="ISNI">0000 0004 0647 2391</institution-id><institution>Department of Family Medicine, </institution><institution>National Health Insurance Service Ilsan Hospital, </institution></institution-wrap>Goyang, Republic of Korea </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01wjejq96</institution-id><institution-id institution-id-type="GRID">grid.15444.30</institution-id><institution-id institution-id-type="ISNI">0000 0004 0470 5454</institution-id><institution>Department of Medicine, </institution><institution>Yonsei University Graduate School, </institution></institution-wrap>Seoul, Republic of Korea </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/04h9pn542</institution-id><institution-id institution-id-type="GRID">grid.31501.36</institution-id><institution-id institution-id-type="ISNI">0000 0004 0470 5905</institution-id><institution>Department of Biomedical Sciences, </institution><institution>Seoul National University Graduate School, </institution></institution-wrap>Seoul, Republic of Korea </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/04ajwkn20</institution-id><institution-id institution-id-type="GRID">grid.459553.b</institution-id><institution-id institution-id-type="ISNI">0000 0004 0647 8021</institution-id><institution>Department of Family Medicine, </institution><institution>Gangnam Severance Hospital, </institution></institution-wrap>Seoul, Republic of Korea </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02tsanh21</institution-id><institution-id institution-id-type="GRID">grid.410914.9</institution-id><institution-id institution-id-type="ISNI">0000 0004 0628 9810</institution-id><institution>National Cancer Control Institute, National Cancer Center, </institution></institution-wrap>Goyang, Republic of Korea </aff><aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/047dqcg40</institution-id><institution-id institution-id-type="GRID">grid.222754.4</institution-id><institution-id institution-id-type="ISNI">0000 0001 0840 2678</institution-id><institution>Department of Biomedical Informatics, </institution><institution>Korea University College of Medicine, </institution></institution-wrap>Seoul, Republic of Korea </aff><aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/03c8k9q07</institution-id><institution-id institution-id-type="GRID">grid.416665.6</institution-id><institution-id institution-id-type="ISNI">0000 0004 0647 2391</institution-id><institution>Department of Orthopedic Surgery, </institution><institution>National Health Insurance Service Ilsan Hospital, </institution></institution-wrap>Goyang, Republic of Korea </aff><aff id="Aff8"><label>8</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01z4nnt86</institution-id><institution-id institution-id-type="GRID">grid.412484.f</institution-id><institution-id institution-id-type="ISNI">0000 0001 0302 820X</institution-id><institution>Department of Family Medicine, </institution><institution>Seoul National University Hospital, </institution></institution-wrap>Seoul, Republic of Korea </aff></contrib-group><pub-date pub-type="epub"><day>11</day><month>10</month><year>2024</year></pub-date><pub-date pub-type="collection"><year>2024</year></pub-date><volume>14</volume><issue-id pub-id-type="pmc-issue-id">452196</issue-id><elocation-id>23850</elocation-id><history><date date-type="received"><day>3</day><month>3</month><year>2024</year></date><date date-type="accepted"><day>30</day><month>9</month><year>2024</year></date></history><pub-history><event event-type="pmc-release"><date><day>11</day><month>10</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>12</day><month>10</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-02-04 07:25:27.717"><day>04</day><month>02</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2024, correceted publication 2024</copyright-statement><copyright-year>2024</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article&#8217;s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article&#8217;s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link>.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="41598_2024_Article_74817.pdf"/><related-article xmlns:xlink="http://www.w3.org/1999/xlink" related-article-type="correction-forward" xml:lang="en" xlink:title="correction" journal-id="Sci Rep" journal-id-type="nlm-ta" ext-link-type="pmc" xlink:href="PMC11754910"><article-title>Author Correction: Tramadol use and incident dementia in older adults with musculoskeletal pain: a population-based retrospective cohort study</article-title><volume>15</volume><date><day>22</day><month>1</month><year>2025</year></date><elocation-id>2845</elocation-id><source>Scientific Reports</source><pub-id pub-id-type="pmcid">PMC11754910</pub-id><pub-id pub-id-type="pmid">39843612</pub-id></related-article><abstract id="Abs1"><p id="Par1">We aimed to assess the association of tramadol use with the risk of dementia. This population-based retrospective cohort study using the Korean National Health Insurance Service database included a total of 1,865,827 older adult patients aged 60&#160;years or older with common musculoskeletal pain between January 1, 2003, and December 31, 2007. Individuals who were newly dispensed tramadol (N&#8201;=&#8201;41,963) were identified and propensity score&#8211;matched with those who were not (N&#8201;=&#8201;41,963). Over a maximum of 14-year follow-up, the incidence rates (events per 1000 person-years) of all-cause dementia were 6.1 for nonusers, 6.2 for those with cumulative tramadol use of 1&#8211;14&#160;days, 7.7 for those with 15&#8211;90&#160;days of use, and 8.0 for those with&#8201;&gt;&#8201;90&#160;days of use. Longer cumulative duration of tramadol use was associated with an increased risk of all-cause dementia compared with nonuse (1 to 14&#160;days: aHR 1.06, 95% CI 0.96&#8211;1.17; 15 to 90&#160;days: aHR 1.14, 95% CI 1.10&#8211;1.35; and more than 90&#160;days: aHR 1.18, 95% CI 1.00&#8211;1.39; test for trend: <italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.001). The results showed a similar pattern for Alzheimer&#8217;s disease and were robust across subgroup and sensitivity analyses, but not for vascular dementia. This study found that exposure to tramadol was associated with an increased risk of dementia. Taking this potential risk into consideration, clinicians should carefully weigh potential benefits and risks when prescribing tramadol to older adults with musculoskeletal pain.</p></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Tramadol</kwd><kwd>Dementia</kwd><kwd>Alzheimer&#8217;s disease</kwd><kwd>Vascular dementia</kwd><kwd>Pain</kwd></kwd-group><kwd-group kwd-group-type="npg-subject"><title>Subject terms</title><kwd>Neurological disorders</kwd><kwd>Dementia</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; Springer Nature Limited 2024</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par2">Musculoskeletal pain conditions are the leading cause of disability worldwide<sup><xref ref-type="bibr" rid="CR1">1</xref></sup>. Improving the quality of care for musculoskeletal pain conditions is an urgent necessity. One problem in musculoskeletal pain care is the overuse of opioids<sup><xref ref-type="bibr" rid="CR2">2</xref></sup>. While overall prescribing of opioids for chronic pain has been reduced as being restricted by guidelines due to their potential harm<sup><xref ref-type="bibr" rid="CR3">3</xref>&#8211;<xref ref-type="bibr" rid="CR5">5</xref></sup>, the prescription of weak opioids continues to remain high<sup><xref ref-type="bibr" rid="CR6">6</xref>&#8211;<xref ref-type="bibr" rid="CR8">8</xref></sup>.</p><p id="Par3">Tramadol is a weak mu opioid receptor agonist and serotonin and norepinephrine reuptake inhibitor<sup><xref ref-type="bibr" rid="CR9">9</xref></sup>. Due to its multiple analgesic mechanisms and perception as a relatively safe opioid, the use of tramadol has been increasing rapidly around the world over the past few decades<sup><xref ref-type="bibr" rid="CR7">7</xref>,<xref ref-type="bibr" rid="CR10">10</xref>,<xref ref-type="bibr" rid="CR11">11</xref></sup>. However, the evidence of the effects of tramadol on musculoskeletal pain conditions has been inconsistent<sup><xref ref-type="bibr" rid="CR12">12</xref>,<xref ref-type="bibr" rid="CR13">13</xref></sup>. Furthermore, there is growing evidence of multiple adverse outcomes by its mechanistic combination<sup><xref ref-type="bibr" rid="CR14">14</xref>&#8211;<xref ref-type="bibr" rid="CR17">17</xref></sup>. In particular, tramadol has been prescribed more frequently and for longer durations among older adults patients compared to younger individuals<sup><xref ref-type="bibr" rid="CR10">10</xref>,<xref ref-type="bibr" rid="CR11">11</xref>,<xref ref-type="bibr" rid="CR18">18</xref></sup>. In older adults, chronic tramadol use has been associated with an increased risk of safety events, such as cardiovascular events, falls, hip fractures, emergency room visits, and hospitalization<sup><xref ref-type="bibr" rid="CR19">19</xref></sup>.</p><p id="Par4">Recent observational studies have reported that long-term opioid use increases the risk of cognitive decline or dementia<sup><xref ref-type="bibr" rid="CR20">20</xref>&#8211;<xref ref-type="bibr" rid="CR23">23</xref></sup>. Although animal studies have shown that chronic exposure to tramadol induces hippocampal atrophy and subsequent learning and memory impairment<sup><xref ref-type="bibr" rid="CR24">24</xref>&#8211;<xref ref-type="bibr" rid="CR27">27</xref></sup>, the evidence regarding the association of long-term tramadol use with dementia remains scarce. An observational study reported that the tramadol use was not associated with an increased risk of Alzheimer&#8217;s disease (AD) compared to non-use<sup><xref ref-type="bibr" rid="CR28">28</xref></sup>. However, the study had several limitations, including not accounting for the competing risk of death and not controlling for the lifestyle behaviors which could be important confounders in the association between tramadol and dementia. Moreover, the exposure definition of the study was lacking the duration of tramadol usage.</p><p id="Par5">Therefore, this population-based retrospective cohort study, using the Korean National Health Insurance Service (NHIS) database, aimed to investigate the association between cumulative use of tramadol and the risk of all-cause dementia, AD, and vascular dementia (VaD), in older adult patients with musculoskeletal pain. We hypothesized that longer cumulative use of tramadol would be associated with increased dementia risk.</p></sec><sec id="Sec2"><title>Results</title><sec id="Sec3"><title>Study population and baseline characteristics</title><p id="Par6">Figure&#160;<xref rid="Fig1" ref-type="fig">1</xref> shows the participant selection process for this study. A total of 1,865,827 older adult patients aged 60&#160;years or older with musculoskeletal pain and complete information were identified between January 1, 2003, and December 31, 2007. We excluded patients with cancer (n&#8201;=&#8201;69,918), dementia (n&#8201;=&#8201;52,583), stroke (n&#8201;=&#8201;279,661), opioid use disorder (n&#8201;=&#8201;554), other opioid use (n&#8201;=&#8201;1,221,443), and those who died before the index date (n&#8201;=&#8201;1,330). Participants who were dispensed tramadol were matched with those who were not, resulting in the exclusion of 156,412 unmatched participants. The final analytic cohort consisted of 83,926 participants, including 41,963 tramadol users and 41,963 nonusers. Table <xref rid="Tab1" ref-type="table">1</xref> shows the baseline characteristics of the study population before and after the propensity score matching. The median (interquartile range) age of the tramadol user group was 67 (63&#8211;72) years, and 56.7% were women. Standardized differences were calculated to assess the balance achieved between tramadol users and nonusers after matching. The balance of baseline characteristics across both groups improved with propensity score matching.<fig id="Fig1" position="float" orientation="portrait"><label>Fig. 1</label><caption><p>Selection process of participants.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO1" position="float" orientation="portrait" xlink:href="41598_2024_74817_Fig1_HTML.jpg"/></fig><table-wrap id="Tab1" position="float" orientation="portrait"><label>Table 1</label><caption><p>Baseline characteristics of study participants before and after propensity score matching.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2" colspan="1">Characteristics</th><th align="left" colspan="3" rowspan="1">Before PS matching</th><th align="left" colspan="3" rowspan="1">After PS matching</th></tr><tr><th align="left" colspan="1" rowspan="1">Tramadol users (n&#8201;=&#8201;43,280)</th><th align="left" colspan="1" rowspan="1">Nonusers (n&#8201;=&#8201;197,058)</th><th align="left" colspan="1" rowspan="1">Standardized difference</th><th align="left" colspan="1" rowspan="1">Tramadol users (n&#8201;=&#8201;41,963)</th><th align="left" colspan="1" rowspan="1">Nonusers (n&#8201;=&#8201;41,963)</th><th align="left" colspan="1" rowspan="1">Standardized difference</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Age, median (IQR), year</td><td char="(" align="char" colspan="1" rowspan="1">67 (63&#8211;72)</td><td char="(" align="char" colspan="1" rowspan="1">67 (63&#8211;71)</td><td char="." align="char" colspan="1" rowspan="1">&#8201;&#8722;&#8201;0.0821</td><td char="(" align="char" colspan="1" rowspan="1">67 (63&#8211;72)</td><td char="(" align="char" colspan="1" rowspan="1">68 (63&#8211;72)</td><td char="." align="char" colspan="1" rowspan="1">0.0276</td></tr><tr><td char="." align="char" colspan="7" rowspan="1">Sex</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Male</td><td char="(" align="char" colspan="1" rowspan="1">18,562 (42.9)</td><td char="(" align="char" colspan="1" rowspan="1">96,728 (49.1)</td><td char="." align="char" colspan="1" rowspan="1">0.1246</td><td char="(" align="char" colspan="1" rowspan="1">18,181 (43.3)</td><td char="(" align="char" colspan="1" rowspan="1">17,352 (41.4)</td><td char="." align="char" colspan="1" rowspan="1">&#8201;&#8722;&#8201;0.0401</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Female</td><td char="(" align="char" colspan="1" rowspan="1">24,718 (57.1)</td><td char="(" align="char" colspan="1" rowspan="1">100,330 (50.9)</td><td char="." align="char" colspan="1" rowspan="1">&#8201;&#8722;&#8201;0.1246</td><td char="(" align="char" colspan="1" rowspan="1">23,782 (56.7)</td><td char="(" align="char" colspan="1" rowspan="1">24,611 (58.6)</td><td char="." align="char" colspan="1" rowspan="1">0.0401</td></tr><tr><td char="." align="char" colspan="7" rowspan="1">Household income</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Upper half</td><td char="(" align="char" colspan="1" rowspan="1">27,003 (62.4)</td><td char="(" align="char" colspan="1" rowspan="1">121,146 (61.5)</td><td char="." align="char" colspan="1" rowspan="1">0.0890</td><td char="(" align="char" colspan="1" rowspan="1">26,165 (62.4)</td><td char="(" align="char" colspan="1" rowspan="1">26,309 (62.7)</td><td char="." align="char" colspan="1" rowspan="1">0.0072</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Lower Half</td><td char="(" align="char" colspan="1" rowspan="1">16,277 (37.6)</td><td char="(" align="char" colspan="1" rowspan="1">75,912 (38.5)</td><td char="." align="char" colspan="1" rowspan="1">0.0187</td><td char="(" align="char" colspan="1" rowspan="1">15,798 (37.6)</td><td char="(" align="char" colspan="1" rowspan="1">15,654 (37.3)</td><td char="." align="char" colspan="1" rowspan="1">&#8201;&#8722;&#8201;0.0072</td></tr><tr><td char="." align="char" colspan="7" rowspan="1">CCI</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;0</td><td char="(" align="char" colspan="1" rowspan="1">17,782 (41.1)</td><td char="(" align="char" colspan="1" rowspan="1">104,501 (53.0)</td><td char="." align="char" colspan="1" rowspan="1">0.2409</td><td char="(" align="char" colspan="1" rowspan="1">17,511 (41.7)</td><td char="(" align="char" colspan="1" rowspan="1">15,844 (37.8)</td><td char="." align="char" colspan="1" rowspan="1">&#8201;&#8722;&#8201;0.0812</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;1</td><td char="(" align="char" colspan="1" rowspan="1">11,987 (27.7)</td><td char="(" align="char" colspan="1" rowspan="1">49,048 (24.9)</td><td char="." align="char" colspan="1" rowspan="1">&#8201;&#8722;&#8201;0.0639</td><td char="(" align="char" colspan="1" rowspan="1">11,626 (27.7)</td><td char="(" align="char" colspan="1" rowspan="1">11,738 (28.0)</td><td char="." align="char" colspan="1" rowspan="1">0.0058</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#8201;&#8805;&#8201;2</td><td char="(" align="char" colspan="1" rowspan="1">13,511 (31.2)</td><td char="(" align="char" colspan="1" rowspan="1">43,509 (22.1)</td><td char="." align="char" colspan="1" rowspan="1">&#8201;&#8722;&#8201;0.2078</td><td char="(" align="char" colspan="1" rowspan="1">12,826 (30.6)</td><td char="(" align="char" colspan="1" rowspan="1">14,381 (34.2)</td><td char="." align="char" colspan="1" rowspan="1">0.0791</td></tr><tr><td align="left" colspan="1" rowspan="1">Cumulative NSAIDs use, median (IQR), day</td><td char="(" align="char" colspan="1" rowspan="1">111 (45&#8211;279)</td><td char="(" align="char" colspan="1" rowspan="1">46 (17&#8211;113)</td><td char="." align="char" colspan="1" rowspan="1">&#8201;&#8722;&#8201;0.4975</td><td char="(" align="char" colspan="1" rowspan="1">107 (44&#8211;259)</td><td char="(" align="char" colspan="1" rowspan="1">76 (25&#8211;239)</td><td char="." align="char" colspan="1" rowspan="1">0.0720</td></tr><tr><td align="left" colspan="1" rowspan="1">Cumulative Acetaminophen use, median (IQR), day</td><td char="(" align="char" colspan="1" rowspan="1">17 (6&#8211;47)</td><td char="(" align="char" colspan="1" rowspan="1">0 (0&#8211;8)</td><td char="." align="char" colspan="1" rowspan="1">&#8201;&#8722;&#8201;0.4093</td><td char="(" align="char" colspan="1" rowspan="1">16 (6&#8211;42)</td><td char="(" align="char" colspan="1" rowspan="1">3 (0&#8211;20)</td><td char="." align="char" colspan="1" rowspan="1">&#8201;&#8722;&#8201;0.0890</td></tr><tr><td align="left" colspan="1" rowspan="1">Cumulative Antidepressant use, median (IQR), day</td><td char="(" align="char" colspan="1" rowspan="1">0 (0&#8211;4)</td><td char="(" align="char" colspan="1" rowspan="1">0 (0&#8211;0)</td><td char="." align="char" colspan="1" rowspan="1">&#8722;0.1039</td><td char="(" align="char" colspan="1" rowspan="1">0 (0&#8211;3)</td><td char="(" align="char" colspan="1" rowspan="1">0 (0&#8211;0)</td><td char="." align="char" colspan="1" rowspan="1">0.0154</td></tr><tr><td char="." align="char" colspan="7" rowspan="1">Cigarette smoking</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Smoker</td><td char="(" align="char" colspan="1" rowspan="1">6204 (14.3)</td><td char="(" align="char" colspan="1" rowspan="1">32,109 (16.3)</td><td char="." align="char" colspan="1" rowspan="1">0.0545</td><td char="(" align="char" colspan="1" rowspan="1">6079 (14.5)</td><td char="(" align="char" colspan="1" rowspan="1">5693 (13.6)</td><td char="." align="char" colspan="1" rowspan="1">&#8201;&#8722;&#8201;0.0265</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Non-smoker</td><td char="(" align="char" colspan="1" rowspan="1">37,076 (85.7)</td><td char="(" align="char" colspan="1" rowspan="1">164,949 (83.7)</td><td char="." align="char" colspan="1" rowspan="1">&#8201;&#8722;&#8201;0.0545</td><td char="(" align="char" colspan="1" rowspan="1">35,884 (85.5)</td><td char="(" align="char" colspan="1" rowspan="1">36,270 (86.4)</td><td char="." align="char" colspan="1" rowspan="1">0.0265</td></tr><tr><td char="." align="char" colspan="7" rowspan="1">Alcohol consumption</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Non-drinker</td><td char="(" align="char" colspan="1" rowspan="1">31,544 (72.9)</td><td char="(" align="char" colspan="1" rowspan="1">135,789 (68.9)</td><td char="." align="char" colspan="1" rowspan="1">&#8201;&#8722;&#8201;0.0875</td><td char="(" align="char" colspan="1" rowspan="1">30,442 (72.5)</td><td char="(" align="char" colspan="1" rowspan="1">30,876 (73.6)</td><td char="." align="char" colspan="1" rowspan="1">0.0234</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;1&#8211;2&#160;days/week</td><td char="(" align="char" colspan="1" rowspan="1">3023 (7.0)</td><td char="(" align="char" colspan="1" rowspan="1">15,507 (7.9)</td><td char="." align="char" colspan="1" rowspan="1">0.0340</td><td char="(" align="char" colspan="1" rowspan="1">2959 (7.1)</td><td char="(" align="char" colspan="1" rowspan="1">2932 (7.0)</td><td char="." align="char" colspan="1" rowspan="1">&#8201;&#8722;&#8201;0.0023</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#8201;&#8805;&#8201;3&#160;days/week</td><td char="(" align="char" colspan="1" rowspan="1">8713 (20.1)</td><td char="(" align="char" colspan="1" rowspan="1">45,762 (23.2)</td><td char="." align="char" colspan="1" rowspan="1">0.0750</td><td char="(" align="char" colspan="1" rowspan="1">8562 (20.4)</td><td char="(" align="char" colspan="1" rowspan="1">8155 (19.4)</td><td char="." align="char" colspan="1" rowspan="1">&#8201;&#8722;&#8201;0.0243</td></tr><tr><td char="." align="char" colspan="7" rowspan="1">Physical activity</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;None</td><td char="(" align="char" colspan="1" rowspan="1">29,707 (68.6)</td><td char="(" align="char" colspan="1" rowspan="1">123,652 (62.8)</td><td char="." align="char" colspan="1" rowspan="1">&#8201;&#8722;&#8201;0.1243</td><td char="(" align="char" colspan="1" rowspan="1">28,704 (68.4)</td><td char="(" align="char" colspan="1" rowspan="1">28,594 (68.1)</td><td char="." align="char" colspan="1" rowspan="1">&#8201;&#8722;&#8201;0.0056</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;1&#8211;2&#160;days/week</td><td char="(" align="char" colspan="1" rowspan="1">5764 (13.3)</td><td char="(" align="char" colspan="1" rowspan="1">31,137 (15.8)</td><td char="." align="char" colspan="1" rowspan="1">0.0715</td><td char="(" align="char" colspan="1" rowspan="1">5612 (13.4)</td><td char="(" align="char" colspan="1" rowspan="1">5639 (13.4)</td><td char="." align="char" colspan="1" rowspan="1">0.0021</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#8201;&#8805;&#8201;3&#160;days/week</td><td char="(" align="char" colspan="1" rowspan="1">7827 (18.1)</td><td char="(" align="char" colspan="1" rowspan="1">42,269 (21.4)</td><td char="." align="char" colspan="1" rowspan="1">0.0847</td><td char="(" align="char" colspan="1" rowspan="1">7647 (18.2)</td><td char="(" align="char" colspan="1" rowspan="1">7730 (18.4)</td><td char="." align="char" colspan="1" rowspan="1">0.0052</td></tr><tr><td align="left" colspan="1" rowspan="1">Body mass index, median (IQR), kg/m<sup>2</sup></td><td char="(" align="char" colspan="1" rowspan="1">23.8 (21.8&#8211;26.0)</td><td char="(" align="char" colspan="1" rowspan="1">23.6 (21.6&#8211;25.7)</td><td char="." align="char" colspan="1" rowspan="1">&#8201;&#8722;&#8201;0.0695</td><td char="(" align="char" colspan="1" rowspan="1">23.8 (21.8&#8211;26.0)</td><td char="(" align="char" colspan="1" rowspan="1">23.9 (21.8&#8211;26.0)</td><td char="." align="char" colspan="1" rowspan="1">0.0216</td></tr><tr><td align="left" colspan="1" rowspan="1">Systolic blood pressure, median (IQR), mmHg</td><td char="(" align="char" colspan="1" rowspan="1">130 (120&#8211;140)</td><td char="(" align="char" colspan="1" rowspan="1">130 (120&#8211;140)</td><td char="." align="char" colspan="1" rowspan="1">&#8201;&#8722;&#8201;0.0056</td><td char="(" align="char" colspan="1" rowspan="1">130 (120&#8211;140)</td><td char="(" align="char" colspan="1" rowspan="1">130 (120&#8211;140)</td><td char="." align="char" colspan="1" rowspan="1">0.0122</td></tr><tr><td align="left" colspan="1" rowspan="1">Fasting blood glucose, median (IQR), mg/dL</td><td char="(" align="char" colspan="1" rowspan="1">95 (86&#8211;107)</td><td char="(" align="char" colspan="1" rowspan="1">96 (86&#8211;108)</td><td char="." align="char" colspan="1" rowspan="1">0.0064</td><td char="(" align="char" colspan="1" rowspan="1">95 (86&#8211;107)</td><td char="(" align="char" colspan="1" rowspan="1">96 (86&#8211;108)</td><td char="." align="char" colspan="1" rowspan="1">0.0160</td></tr><tr><td align="left" colspan="1" rowspan="1">Total cholesterol, median (IQR), mg/dL</td><td char="(" align="char" colspan="1" rowspan="1">199 (174&#8211;225)</td><td char="(" align="char" colspan="1" rowspan="1">198 (173&#8211;224)</td><td char="." align="char" colspan="1" rowspan="1">&#8201;&#8722;&#8201;0.0396</td><td char="(" align="char" colspan="1" rowspan="1">199 (174&#8211;225)</td><td char="(" align="char" colspan="1" rowspan="1">199 (174&#8211;226)</td><td char="." align="char" colspan="1" rowspan="1">0.0117</td></tr></tbody></table><table-wrap-foot><p>Data are presented as n (%), unless stated otherwise.</p><p><italic toggle="yes">PS</italic> propensity score, <italic toggle="yes">IQR</italic> interquartile range, <italic toggle="yes">CCI</italic> charlson comorbidity index, <italic toggle="yes">NSAIDs</italic> non-steroidal anti-inflammatory drugs.</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec4"><title>Association of cumulative duration of tramadol dispensation with incident dementia</title><p id="Par7">During the follow-up period of 14&#160;years, the incidence rates (events per 1000 person-years) of all-cause dementia were 6.1 for nonusers, 6.2 for those with cumulative tramadol use of 1&#8211;14&#160;days, 7.7 for those with 15&#8211;90&#160;days of use, and 8.0 for those with&#8201;&gt;&#8201;90&#160;days of use. The median (interquartile range) duration of follow-up for tramadol users and nonusers were 3.34 (1.24&#8211;7.08) years and 3.86 (1.36&#8211;7.86) years, respectively. Table <xref rid="Tab2" ref-type="table">2</xref> shows a dose&#8211;response relationship for all-cause dementia with 5-year cumulative duration of tramadol use (test for trend, <italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.001). Compared with nonusers, those with cumulative use of 1&#8211;14&#160;days (aHR 1.06, 95% CI 0.96&#8211;1.17), 15&#8211;90&#160;days (aHR 1.14, 95% CI 1.10&#8211;1.35), and&#8201;&gt;&#8201;90&#160;days (aHR 1.18, 95% CI 1.00&#8211;1.39) had an increased risk for all-cause dementia. Similar patterns were observed for AD, but not for VaD, as shown in Supplementary Table <xref rid="MOESM1" ref-type="media">1</xref>.<table-wrap id="Tab2" position="float" orientation="portrait"><label>Table 2</label><caption><p>Risk of all-cause dementia associated with 5-year cumulative duration of tramadol use among older adult patients with common musculoskeletal pain.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2" colspan="1"/><th align="left" colspan="4" rowspan="1">5-Year cumulative duration of tramadol use, day</th><th align="left" rowspan="2" colspan="1"><italic toggle="yes">P</italic> for trend</th></tr><tr><th align="left" colspan="1" rowspan="1">0 (n&#8201;=&#8201;41,963)</th><th align="left" colspan="1" rowspan="1">1&#8211;14 (n&#8201;=&#8201;22,816)</th><th align="left" colspan="1" rowspan="1">15&#8211;90 (n&#8201;=&#8201;14,601)</th><th align="left" colspan="1" rowspan="1">&#8201;&gt;&#8201;90 (n&#8201;=&#8201;4546)</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Events/1000 person-years</td><td char="." align="char" colspan="1" rowspan="1">6.1</td><td align="left" colspan="1" rowspan="1">6.2</td><td align="left" colspan="1" rowspan="1">7.7</td><td align="left" colspan="1" rowspan="1">8.0</td><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Age and sex-adjusted model</td><td char="." align="char" colspan="1" rowspan="1">1.00 (Reference)</td><td align="left" colspan="1" rowspan="1">1.04 (0.94&#8211;1.14)</td><td align="left" colspan="1" rowspan="1">1.22 (1.10&#8211;1.35)***</td><td align="left" colspan="1" rowspan="1">1.21 (1.03&#8211;1.42)*</td><td char="." align="char" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">Multivariable Model 1</td><td char="." align="char" colspan="1" rowspan="1">1.00 (Reference)</td><td align="left" colspan="1" rowspan="1">1.06 (0.96&#8211;1.16)</td><td align="left" colspan="1" rowspan="1">1.22 (1.10&#8211;1.35)***</td><td align="left" colspan="1" rowspan="1">1.18 (1.00&#8211;1.39)</td><td char="." align="char" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">Multivariable Model 2</td><td char="." align="char" colspan="1" rowspan="1">1.00 (Reference)</td><td align="left" colspan="1" rowspan="1">1.06 (0.96&#8211;1.17)</td><td align="left" colspan="1" rowspan="1">1.14 (1.10&#8211;1.35)***</td><td align="left" colspan="1" rowspan="1">1.18 (1.00&#8211;1.39)***</td><td char="." align="char" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.001</td></tr></tbody></table><table-wrap-foot><p>Multivariable model 1&#8201;=&#8201;the Fine-Gray subdistribution hazard model adjusted for age, sex, household income, Charlson Comorbidity Index, non-steroidal anti-inflammatory drugs use, acetaminophen use, and antidepressants use; Multivariable model 2&#8201;=&#8201;the Fine-Gray subdistribution hazard model adjusted for cigarette smoking, alcohol consumption, physical activity, body mass index, systolic blood pressure, fasting serum glucose, and total cholesterol in addition to the variables included in multivariable model 1.</p><p>*<italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.05.</p><p>***<italic toggle="yes">P</italic>&#8201;&lt;0&#8201;.001.</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec5"><title>Subgroup and sensitivity analyses</title><p id="Par8">Table <xref rid="Tab3" ref-type="table">3</xref> depicts the results from a subgroup analysis of the association between tramadol use and all-cause dementia according to sex, household income, cigarette smoking, alcohol consumption, physical activity, and comorbidities. The association between tramadol use and incident dementia did not differ significantly across these stratifying variables (<italic toggle="yes">P</italic> for interaction&#8201;&gt;&#8201;0.05).<table-wrap id="Tab3" position="float" orientation="portrait"><label>Table 3</label><caption><p>Subgroup analyses for the risk of all-cause dementia associated with 5-year cumulative duration of tramadol use among older adult patients with common musculoskeletal pain.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2" colspan="1">Characteristic</th><th align="left" colspan="4" rowspan="1">5-Year Cumulative duration of tramadol use, day</th><th align="left" rowspan="2" colspan="1"><italic toggle="yes">P</italic> for trend</th><th align="left" rowspan="2" colspan="1"><italic toggle="yes">P</italic> for interaction</th></tr><tr><th align="left" colspan="1" rowspan="1">0</th><th align="left" colspan="1" rowspan="1">1&#8211;14</th><th align="left" colspan="1" rowspan="1">15&#8211;90</th><th align="left" colspan="1" rowspan="1">&#8201;&gt;&#8201;90</th></tr></thead><tbody><tr><td align="left" colspan="7" rowspan="1">Sex</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Male</td><td align="left" colspan="1" rowspan="1">1.00 (Reference)</td><td align="left" colspan="1" rowspan="1">0.92 (0.77&#8211;1.09)</td><td align="left" colspan="1" rowspan="1">1.20 (1.01&#8211;1.44)*</td><td align="left" colspan="1" rowspan="1">1.10 (0.80&#8211;1.52)</td><td char="." align="char" colspan="1" rowspan="1">0.134</td><td align="left" rowspan="2" colspan="1">0.298</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Female</td><td align="left" colspan="1" rowspan="1">1.00 (Reference)</td><td align="left" colspan="1" rowspan="1">1.13 (1.01&#8211;1.27)</td><td align="left" colspan="1" rowspan="1">1.23 (1.09&#8211;1.39)**</td><td align="left" colspan="1" rowspan="1">1.22 (1.00&#8211;1.49)*</td><td char="." align="char" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.001</td></tr><tr><td align="left" colspan="7" rowspan="1">Household income</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Upper half</td><td align="left" colspan="1" rowspan="1">1.00 (Reference)</td><td align="left" colspan="1" rowspan="1">1.01 (0.90&#8211;1.14)</td><td align="left" colspan="1" rowspan="1">1.21 (1.06&#8211;1.37)**</td><td align="left" colspan="1" rowspan="1">1.20 (0.98&#8211;1.47)</td><td char="." align="char" colspan="1" rowspan="1">0.004</td><td align="left" rowspan="2" colspan="1">0.604</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Lower half</td><td align="left" colspan="1" rowspan="1">1.00 (Reference)</td><td align="left" colspan="1" rowspan="1">1.16 (0.99&#8211;1.36)</td><td align="left" colspan="1" rowspan="1">1.25 (1.05&#8211;1.49)*</td><td align="left" colspan="1" rowspan="1">1.14 (0.85&#8211;1.53)</td><td char="." align="char" colspan="1" rowspan="1">0.014</td></tr><tr><td align="left" colspan="7" rowspan="1">Cigarette smoking</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Non-smoker</td><td align="left" colspan="1" rowspan="1">1.00 (Reference)</td><td align="left" colspan="1" rowspan="1">1.06 (0.96&#8211;1.17)</td><td align="left" colspan="1" rowspan="1">1.23 (1.11&#8211;1.37)***</td><td align="left" colspan="1" rowspan="1">1.20 (1.00&#8211;1.43)*</td><td char="." align="char" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.001</td><td align="left" rowspan="2" colspan="1">0.927</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Smoker</td><td align="left" colspan="1" rowspan="1">1.00 (Reference)</td><td align="left" colspan="1" rowspan="1">1.05 (0.80&#8211;1.38)</td><td align="left" colspan="1" rowspan="1">1.14 (0.84&#8211;1.55)</td><td align="left" colspan="1" rowspan="1">1.03 (0.62&#8211;1.71)</td><td char="." align="char" colspan="1" rowspan="1">0.488</td></tr><tr><td align="left" colspan="7" rowspan="1">Alcohol consumption</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Non-drinker</td><td align="left" colspan="1" rowspan="1">1.00 (Reference)</td><td align="left" colspan="1" rowspan="1">1.06 (0.96&#8211;1.18)</td><td align="left" colspan="1" rowspan="1">1.22 (1.09&#8211;1.37)***</td><td align="left" colspan="1" rowspan="1">1.20 (1.00&#8211;1.44)</td><td char="." align="char" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.001</td><td align="left" rowspan="2" colspan="1">0.980</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Drinker</td><td align="left" colspan="1" rowspan="1">1.00 (Reference)</td><td align="left" colspan="1" rowspan="1">1.05 (0.85&#8211;1.29)</td><td align="left" colspan="1" rowspan="1">1.23 (0.98&#8211;1.54)</td><td align="left" colspan="1" rowspan="1">1.09 (0.72&#8211;1.64)</td><td char="." align="char" colspan="1" rowspan="1">0.144</td></tr><tr><td align="left" colspan="7" rowspan="1">Physical activity</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Physically active</td><td align="left" colspan="1" rowspan="1">1.00 (Reference)</td><td align="left" colspan="1" rowspan="1">1.05 (0.88&#8211;1.27)</td><td align="left" colspan="1" rowspan="1">1.30 (1.07&#8211;1.58)**</td><td align="left" colspan="1" rowspan="1">1.08 (0.76&#8211;1.53)</td><td char="." align="char" colspan="1" rowspan="1">0.040</td><td align="left" rowspan="2" colspan="1">0.708</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Physically inactive</td><td align="left" colspan="1" rowspan="1">1.00 (Reference)</td><td align="left" colspan="1" rowspan="1">1.06 (0.95&#8211;1.19)</td><td align="left" colspan="1" rowspan="1">1.19 (1.06&#8211;1.35)**</td><td align="left" colspan="1" rowspan="1">1.21 (1.00&#8211;1.47)*</td><td char="." align="char" colspan="1" rowspan="1">0.002</td></tr><tr><td align="left" colspan="7" rowspan="1">Charlson comorbidity index</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;0</td><td align="left" colspan="1" rowspan="1">1.00 (Reference)</td><td align="left" colspan="1" rowspan="1">1.09 (0.94&#8211;1.26)</td><td align="left" colspan="1" rowspan="1">1.20 (1.01&#8211;1.42)*</td><td align="left" colspan="1" rowspan="1">1.32 (1.01&#8211;1.74)*</td><td char="." align="char" colspan="1" rowspan="1">0.008</td><td align="left" rowspan="3" colspan="1">0.451</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;1</td><td align="left" colspan="1" rowspan="1">1.00 (Reference)</td><td align="left" colspan="1" rowspan="1">1.09 (0.90&#8211;1.32)</td><td align="left" colspan="1" rowspan="1">1.14 (0.92&#8211;1.41)</td><td align="left" colspan="1" rowspan="1">1.20 (0.84&#8211;1.72)</td><td char="." align="char" colspan="1" rowspan="1">0.134</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#8201;&#8805;&#8201;2</td><td align="left" colspan="1" rowspan="1">1.00 (Reference)</td><td align="left" colspan="1" rowspan="1">1.01 (0.85&#8211;1.18)</td><td align="left" colspan="1" rowspan="1">1.31 (1.11&#8211;1.53)**</td><td align="left" colspan="1" rowspan="1">1.08 (0.83&#8211;1.40)</td><td char="." align="char" colspan="1" rowspan="1">0.017</td></tr></tbody></table><table-wrap-foot><p>Results above are presented as adjusted subdistribution hazard ratio and 95% confidence interval from the Fine-Gray subdistribution hazard model adjusted for age, sex, household income, Charlson Comorbidity Index, non-steroidal anti-inflammatory drugs use, acetaminophen use, antidepressants use, cigarette smoking, alcohol consumption, physical activity, body mass index, systolic blood pressure, fasting serum glucose, and total cholesterol except for the variable in the relevant category.</p><p>*<italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.05.</p><p>**<italic toggle="yes">P</italic>&#8201;&lt;0&#8201;.01.</p><p>***<italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.001.</p></table-wrap-foot></table-wrap></p><p id="Par9">The sensitivity analyses which introduced the lag time window from 1 to 3&#160;years showed results similar to the main analysis. (Supplementary Tables <xref rid="MOESM1" ref-type="media">2</xref>, <xref rid="MOESM1" ref-type="media">3</xref>, <xref rid="MOESM1" ref-type="media">4</xref>). Also, the analyses that defined dementia solely based on ICD-10 codes indicated no appreciable change in risk estimates for all-cause dementia, AD, and VaD (Supplementary Table <xref rid="MOESM1" ref-type="media">5</xref>). Furthermore, the analyses excluding tramadol users who received only one prescription also showed results similar to the main analysis (Supplementary Table <xref rid="MOESM1" ref-type="media">6</xref>).</p></sec></sec><sec id="Sec6"><title>Discussion</title><p id="Par10">In this retrospective population-based cohort study of older adults with common musculoskeletal pain aged 60&#160;years or older, tramadol use was associated with an increased risk of all-cause dementia and AD over 14&#160;years of follow-up compared with nonuse, and the risk increased with increasing cumulative duration of tramadol use. Our findings remained consistent and robust across the subgroup and sensitivity analyses.</p><p id="Par11">Tramadol is a weak opioid used for moderate pain in the second step of the World Health Organization pain ladder<sup><xref ref-type="bibr" rid="CR29">29</xref></sup>. It also has serotonin and norepinephrine reuptake inhibitory activity, contributing to its analgesic effects<sup><xref ref-type="bibr" rid="CR9">9</xref></sup>. To our knowledge, this is the first study to demonstrate that tramadol is associated with an increased risk of developing dementia. Two recent studies reported an association between long-term opioid use and increased risk of dementia<sup><xref ref-type="bibr" rid="CR22">22</xref>,<xref ref-type="bibr" rid="CR23">23</xref></sup>. One prospective cohort study of 91,307 persons using the Israeli nationwide health maintenance organizations database reported that opioid purchase more than 60&#160;days was associated with an increased risk of dementia among individuals aged 75 to 80 compared to nonuse (aHR 1.39, 95% CI 1.01&#8211;1.92, <italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.05)<sup><xref ref-type="bibr" rid="CR22">22</xref></sup>. Another retrospective cohort study of 41,636 chronic pain patients in China reported that opioid use of 180 defined daily doses per year or more was associated with an increased risk of dementia compared to nonuse (aHR 1.86, 95% CI 1.25&#8211;2.09, <italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.001)<sup><xref ref-type="bibr" rid="CR23">23</xref></sup>. The findings from observational studies examining the association between serotonin and norepinephrine reuptake inhibitors use and dementia have been mixed<sup><xref ref-type="bibr" rid="CR30">30</xref>,<xref ref-type="bibr" rid="CR31">31</xref></sup>. Our study expanded on prior studies by exploring the association between tramadol and incident dementia and found that, tramadol prescription dispensation was associated with a higher risk of dementia. The results from our study suggest that the dementia risk associated with long-term tramadol use (aHR 1.18, 95% CI 1.00&#8211;1.39, <italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.001) is lower than previously reported in studies involving traditional opioids.</p><p id="Par12">One study presented results that differ from the results of our study. A nested case&#8211;control study of 53,990 persons with AD using the Finnish nationwide health care register database reported that tramadol prescription was not associated with an increased risk for AD (aOR 1.00 [95% CI 0.97 to 1.02])<sup><xref ref-type="bibr" rid="CR28">28</xref></sup>. However, the study did not consider the competing risk of death in the analysis. Additionally, the study lacked the duration of tramadol prescription in its exposure definition and did not consider dementia other than AD as outcomes. Moreover, lifestyle behaviors such as physical activity, cigarette smoking, and alcohol consumption, which are important risk factors for dementia<sup><xref ref-type="bibr" rid="CR32">32</xref></sup>, were not controlled for in the analysis. In our study, further adjustment for lifestyle-related factors did not significantly change the risk estimates, suggesting that these factors may not have a substantial confounding effect on the observed association.</p><p id="Par13">The precise mechanisms through which tramadol may increase the risk of dementia have not been elucidated. In animal studies, chronic tramadol administration have been shown to induce neurodegeneration in various parts of the brain, such as hippocampus, temporal and occipital regions of cerebral cortex, cerebellum, and basal ganglia, leading to impairment in learning, memory, behavior, and motor function<sup><xref ref-type="bibr" rid="CR24">24</xref>&#8211;<xref ref-type="bibr" rid="CR27">27</xref>,<xref ref-type="bibr" rid="CR33">33</xref>&#8211;<xref ref-type="bibr" rid="CR35">35</xref></sup>. The neurotoxicity of tramadol was associated with neurodegenerative pathways such as autophagy, apoptosis, and inflammation caused by astrogliosis, microgliosis, and microglial activation<sup><xref ref-type="bibr" rid="CR24">24</xref></sup>. Furthermore, multiple studies have reported that tramadol use is linked to delirium, particularly in older patients<sup><xref ref-type="bibr" rid="CR36">36</xref>,<xref ref-type="bibr" rid="CR37">37</xref></sup>, which is a risk factor for subsequent development of dementia<sup><xref ref-type="bibr" rid="CR38">38</xref></sup>. O-desmethyltramadol, the potent metabolite of tramadol may cause delirium by inhibiting cholinergic neurotransmission and increasing serotonin and noradrenaline levels<sup><xref ref-type="bibr" rid="CR39">39</xref></sup>. Additionally, recent observational studies have revealed a substantial link between tramadol use and cardiovascular events including stroke, myocardial infarction, heart failure, and cardiac arrhythmia<sup><xref ref-type="bibr" rid="CR14">14</xref>,<xref ref-type="bibr" rid="CR17">17</xref>,<xref ref-type="bibr" rid="CR19">19</xref></sup>, which are powerful risk factors for dementia<sup><xref ref-type="bibr" rid="CR40">40</xref></sup>. Moreover, changes in cerebral vasculature, including those affecting the microcirculation of the subcortical white matter, result in the clinical expression of cognitive impairment caused by other pathologies, including AD<sup><xref ref-type="bibr" rid="CR40">40</xref></sup>. However, further research is necessary to understand the underlying mechanisms.</p><p id="Par14">Despite its strengths, this study has several limitations. First, we were unable to evaluate and adjust for the severity of pain. Since tramadol is indicated for managing moderate to severe pain, confounding by indication could have affected study findings. Additionally, our exposure measure relied on the cumulative duration of the prescription dispensation of tramadol. This could instead reflect anticipated chronicity of pain. Previous studies have shown conflicting evidence regarding the effect of chronic pain on the development of dementia<sup><xref ref-type="bibr" rid="CR41">41</xref>,<xref ref-type="bibr" rid="CR42">42</xref></sup>. Second, the dispensation of a prescription does not necessarily guarantee actual medication consumption. Additionally, tramadol use status could change over the follow-up period, which were not captured in our analysis. Therefore, misclassification of tramadol exposure is possible. Third, since the outcome measurement of this study was based on recorded ICD-10 codes, there is a possibility of under ascertainment of dementia diagnoses in the registers used. Some individuals may have had undiagnosed dementia that did not yet need medical care. Additionally, because the diagnoses of AD and VaD were not based on biomarkers or neuroimaging data, discrepancies may exist between clinical diagnoses and those recorded in claims data, potentially impacting the reliability of our findings. Fourth, tramadol can induce delirium, which may obscure or delay the diagnosis of dementia in some patients, potentially leading to an underestimation of our dementia risk estimates. Fifth, we could not consider time-varying confounders. Finally, despite we considered a wide range of potential confounding factors, given the observational design of the study and the possibility for residual confounding, we could not prove causality.</p><p id="Par15">In conclusion, the results of this population-based retrospective cohort study with a follow-up of 14&#160;years suggested that the use of tramadol was associated with an increased risk of dementia among older adults aged 60&#160;years or older with common musculoskeletal pain, and the risk increased with higher cumulative tramadol usage. Taking this potential risk into account, clinicians should carefully weigh potential benefits and risks when prescribing tramadol to older adults. Further research, including pain severity measurement and consideration of underlying pain conditions, is needed to clarify the association between tramadol use and dementia risk.</p></sec><sec id="Sec7"><title>Methods</title><sec id="Sec8"><title>Data sources</title><p id="Par16">The NHIS databases between 2002 and 2021 were used. The NHIS is a single non-profit health insurer in South Korea, providing insurance coverage to the entire population. It manages a computerized database containing healthcare-related information of individuals, which includes inpatient and outpatient reimbursement claims data, drug prescriptions, diagnoses, procedures, and treatments provided to each patient. Upon request, the NHIS provides researchers a customized database with de-identified information pertaining to the study population<sup><xref ref-type="bibr" rid="CR43">43</xref></sup>. We also used the National Health Screening Program dataset. All NHIS beneficiaries 40&#160;years or older are provided biannual mandatory health screening examinations that includes a self-reported questionnaire for lifestyle and health behavior, anthropometric measurements, blood pressure, and laboratory tests<sup><xref ref-type="bibr" rid="CR44">44</xref></sup>. The validity of NHIS database has been described in detail elsewhere<sup><xref ref-type="bibr" rid="CR43">43</xref>,<xref ref-type="bibr" rid="CR44">44</xref></sup>.</p><p id="Par17">This study was approved by the Institutional Review Board of National Health Insurance Ilsan Hospital, and the requirement for informed consent was waived due to the anonymized nature of the NHIS database (IRB No. NHIMC 2023-02-011). All methods were performed in accordance with the relevant guidelines and regulations of Helsinki declaration of 1964 and its amendments.</p></sec><sec id="Sec9"><title>Study design and population</title><p id="Par18">We conducted a retrospective cohort study of older adults aged 60&#160;years or older who were diagnosed with common musculoskeletal pain conditions (low back pain, neck pain, shoulder pain, and knee pain) between January 1, 2003, and December 31, 2007. The <italic toggle="yes">International Statistical Classification of Diseases and Related Health Problems, Tenth Revision (ICD-10)</italic> codes for the identification of common musculoskeletal pain conditions are provided in Supplementary Table <xref rid="MOESM1" ref-type="media">7</xref><sup><xref ref-type="bibr" rid="CR1">1</xref>,<xref ref-type="bibr" rid="CR2">2</xref></sup>. From this initial pool, we identified those who were or were not newly dispensed tramadol for common musculoskeletal pain conditions. &#8216;New dispensation&#8217; was defined by applying a 1 year washout period (January 1, 2002-December 31, 2002), during which cases having tramadol dispensation were removed. We excluded individuals who had used opioids other than tramadol, those with a history of opioid use disorder, cancer, or stroke, and those diagnosed with dementia or died on or before the index date (January 1, 2008). The list of opioids is provided in Supplementary Table <xref rid="MOESM1" ref-type="media">8</xref>.</p><p id="Par19">Participants who were dispensed tramadol underwent propensity score matching with those who were not. A caliper width equal to 0.2 of the standard deviation of the logit of the propensity score was used for 1:1 matching between tramadol users and nonusers<sup><xref ref-type="bibr" rid="CR45">45</xref></sup>. The following variables were included in the matching process: age, sex, household income, Charlson Comorbidity Index (CCI), nonsteroidal anti-inflammatory drugs (NSAIDs) use, acetaminophen use, antidepressants use, cigarette smoking, alcohol consumption, physical activity, body mass index, systolic blood pressure, fasting serum glucose, and total cholesterol.</p></sec><sec id="Sec10"><title>Exposures</title><p id="Par20">The main exposure was 5&#160;year cumulative duration of tramadol use, computed by summing all days covered by tramadol from January 1, 2003, to December 31, 2007. The cumulative duration was categorized into three groups: 1&#8211;14&#160;days, 15&#8211;90&#160;days, and more than 90&#160;days. The cutoff points were determined based on the clinical interpretability and exposure distribution in the sample<sup><xref ref-type="bibr" rid="CR5">5</xref></sup>. We excluded prescriptions after the index date from the analysis.</p></sec><sec id="Sec11"><title>Study outcomes</title><p id="Par21">We defined dementia cases as individuals prescribed acetylcholinesterase inhibitors (donepezil, galantamine, rivastigmine) or and N-methyl-D-aspartate receptor antagonist (memantine) under ICD-10 codes F00, F01, F02, F03, and G30, based on data from hospitals and primary health care inpatient and outpatient visits. To identify AD and VaD, ICD-10 codes F00 and G30 and ICD-10 code F01, were used, respectively. Prescribing acetylcholinesterase inhibitors or N-methyl-D-aspartate receptor antagonists for dementia requires evidence of cognitive impairment according to the National Health Insurance Reimbursement guidelines. Validation needs a Mini-Mental State Examination score of 26 or below, along with either a Clinical Dementia Rating of 1 or higher or a Global Deterioration Scale score of 3 or more<sup><xref ref-type="bibr" rid="CR46">46</xref></sup>. Starting from the index date, the participants were followed up until the date of dementia diagnosis, date of death, or December 31, 2021, whichever came first. Additionally, the use of other opioids was applied as a censoring criterion during follow-up.</p></sec><sec id="Sec12"><title>Covariates</title><p id="Par22">The study population was characterized at the index date considering the following potential confounders: age (years), sex (female and male), household income (lower half and upper half, derived from insurance premiums), CCI (0, 1, and&#8201;&#8805;&#8201;2), NSAIDs use (days), acetaminophen use (days), antidepressants use (days), cigarette smoking (non-smoker and smoker), alcohol consumption (non-drinker, 1&#8211;2&#160;days/week, and&#8201;&#8805;&#8201;3&#160;days/week), physical activity (none, 1&#8211;2&#160;days/week, and&#8201;&#8805;&#8201;3&#160;days/week), body mass index (kg/m<sup>2</sup>), systolic blood pressure (mmHg), fasting serum glucose (mg/dL), and total cholesterol (mg/dL). The use of NSAIDs, acetaminophen, and antidepressants was quantified in cumulative days of use and adjusted as continuous variables in the analysis. The body mass index was calculated by dividing the participant&#8217;s weight in kilograms by the square of their height in meters.</p></sec><sec id="Sec13"><title>Statistical analyses</title><p id="Par23">We used the Fine-Gray subdistribution hazard model, accounting for the competing risks of death, to determine the subdistribution hazard ratio for the association between cumulative duration of tramadol use and incident dementia<sup><xref ref-type="bibr" rid="CR47">47</xref></sup>. Three adjustment models were employed to estimate the adjusted subdistribution hazard ratios (aHRs) and 95% confidence intervals (CIs) for all-cause dementia, AD, and VaD according to the cumulative duration of tramadol use. The first adjustment model included age and sex, and the second adjustment model included household income, CCI, NSAIDs use, acetaminophen use, and antidepressants use in addition to the covariates in the first model. The third adjustment model included cigarette smoking, alcohol consumption, physical activity, body mass index, systolic blood pressure, fasting serum glucose, and total cholesterol in addition to the covariates in the second model.</p><p id="Par24">In secondary analyses, we conducted a prespecified subgroup analysis and interaction tests on the cohort, categorizing by sex (female and male), household income (upper half and lower half), cigarette smoking (non-smoker and smoker), alcohol consumption (non-drinker and drinker), physical activity (physically active and physically inactive), and CCI (0, 1, and&#8201;&#8805;&#8201;2). We also performed prespecified sensitivity analyses. We included the lag time window from 1 to 3&#160;years and excluded patients with outcomes that occurred during this period from the analysis to diminish reverse causation bias<sup><xref ref-type="bibr" rid="CR48">48</xref></sup>. Additionally, recognizing that patients with dementia might not always be treated with medications, we conducted sensitivity analyses by defining dementia solely based on ICD-10 codes from hospitals and primary health care inpatient and outpatient visits. Furthermore, considering that individuals who continue to fill prescriptions are more likely to use the drugs compared to those who fill only one prescription, we performed sensitivity analyses excluding participants who were prescribed tramadol only once. Statistical significance was considered at <italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.05 in a two-sided manner. All data analyses were conducted using the SAS software (version 9.4; SAS Institute Inc., Cary, NC, USA).</p></sec></sec><sec id="Sec14" sec-type="supplementary-material"><title>Supplementary Information</title><p>
<supplementary-material content-type="local-data" id="MOESM1" position="float" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="41598_2024_74817_MOESM1_ESM.pdf" position="float" orientation="portrait"><caption><p>Supplementary Information.</p></caption></media></supplementary-material>
</p></sec></body><back><fn-group><fn><p>The original online version of this Article was revised: The original version of this Article contained an error in the spelling of the author Kyuwoong Kim which was incorrectly given as Kyu Woong Kim.</p></fn><fn><p><bold>Publisher&#8217;s note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p><bold>Change history</bold></p><p>1/22/2025</p><p>A Correction to this paper has been published: 10.1038/s41598-025-86870-7</p></fn></fn-group><sec><title>Supplementary Information</title><p>The online version contains supplementary material available at 10.1038/s41598-024-74817-3.</p></sec><ack><title>Acknowledgements</title><p>This study used the National Health Insurance Service database (NHIS-2023-1-547). The interpretations and conclusions reported herein do not represent those of the National Health Insurance Service.</p></ack><notes notes-type="author-contribution"><title>Author contributions</title><p>Si Nae Oh and Hye Jun Kim contributed equally as co-first authors. Study concept and design: Si Nae Oh and Sang Min Park. Acquisition of data: Si Nae Oh, Hye Jun Kim, and Sun Jae Park. Analysis and interpretation of data: Si Nae Oh, Hye Jun Kim, Kyuwoong Kim, Seogsong Jeong, and Sang Min Park. Drafting of the manuscript: Si Nae Oh and Hye Jun Kim. Critical revision of the manuscript for important intellectual content: Si Nae Oh, Hye Jun Kim, Jae Yong Shim, Sang Hyun Lee, Joong Won Ha, and Sang Min Park.</p></notes><notes notes-type="data-availability"><title>Data availability</title><p>The data that support the findings of this study are available from National Health Insurance Service but restrictions apply to the availability of these data, which were used under license for the current study, and so are not publicly available. Data are however available from the corresponding author upon reasonable request and with permission of National Health Insurance Service.</p></notes><notes><title>Declarations</title><notes id="FPar1" notes-type="COI-statement"><title>Competing interests</title><p id="Par25">The authors declare no competing interests.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><mixed-citation publication-type="other">Global, regional, and national burden of diseases and injuries for adults 70 years and older: systematic analysis for the Global Burden of Disease 2019 Study. <italic toggle="yes"> BMJ</italic>. <bold> 376</bold>, e068208 (2022).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/bmj-2021-068208</pub-id><pub-id pub-id-type="pmcid">PMC9316948</pub-id><pub-id pub-id-type="pmid">35273014</pub-id></mixed-citation></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lin</surname><given-names>I</given-names></name><name name-style="western"><surname>Wiles</surname><given-names>L</given-names></name><name name-style="western"><surname>Waller</surname><given-names>R</given-names></name><etal/></person-group><article-title>What does best practice care for musculoskeletal pain look like? Eleven consistent recommendations from high-quality clinical practice guidelines: systematic review</article-title><source>Br. J. Sports Med.</source><year>2020</year><volume>54</volume><issue>2</issue><fpage>79</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.1136/bjsports-2018-099878</pub-id><pub-id pub-id-type="pmid">30826805</pub-id></element-citation><mixed-citation id="mc-CR2" publication-type="journal">Lin, I. et al. What does best practice care for musculoskeletal pain look like? Eleven consistent recommendations from high-quality clinical practice guidelines: systematic review. <italic toggle="yes">Br. J. Sports Med.</italic><bold>54</bold>(2), 79&#8211;86 (2020).<pub-id pub-id-type="pmid">30826805</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/bjsports-2018-099878</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dowell</surname><given-names>D</given-names></name><name name-style="western"><surname>Haegerich</surname><given-names>TM</given-names></name><name name-style="western"><surname>Chou</surname><given-names>R</given-names></name></person-group><article-title>CDC guideline for prescribing opioids for chronic pain - United States, 2016</article-title><source>MMWR Recomm. Rep.</source><year>2016</year><volume>65</volume><issue>1</issue><fpage>1</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.15585/mmwr.rr6501e1</pub-id><pub-id pub-id-type="pmid">26987082</pub-id></element-citation><mixed-citation id="mc-CR3" publication-type="journal">Dowell, D., Haegerich, T. M. &amp; Chou, R. CDC guideline for prescribing opioids for chronic pain - United States, 2016. <italic toggle="yes">MMWR Recomm. Rep.</italic><bold>65</bold>(1), 1&#8211;49 (2016).<pub-id pub-id-type="pmid">26987082</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.15585/mmwr.rr6501e1</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dowell</surname><given-names>D</given-names></name><name name-style="western"><surname>Haegerich</surname><given-names>T</given-names></name><name name-style="western"><surname>Chou</surname><given-names>R</given-names></name></person-group><article-title>No shortcuts to safer opioid prescribing</article-title><source>N. Engl. J. Med.</source><year>2019</year><volume>380</volume><issue>24</issue><fpage>2285</fpage><lpage>2287</lpage><pub-id pub-id-type="doi">10.1056/NEJMp1904190</pub-id><pub-id pub-id-type="pmid">31018066</pub-id><pub-id pub-id-type="pmcid">PMC6573011</pub-id></element-citation><mixed-citation id="mc-CR4" publication-type="journal">Dowell, D., Haegerich, T. &amp; Chou, R. No shortcuts to safer opioid prescribing. <italic toggle="yes">N. Engl. J. Med.</italic><bold>380</bold>(24), 2285&#8211;2287 (2019).<pub-id pub-id-type="pmid">31018066</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1056/NEJMp1904190</pub-id><pub-id pub-id-type="pmcid">PMC6573011</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dowell</surname><given-names>D</given-names></name><name name-style="western"><surname>Ragan</surname><given-names>KR</given-names></name><name name-style="western"><surname>Jones</surname><given-names>CM</given-names></name><name name-style="western"><surname>Baldwin</surname><given-names>GT</given-names></name><name name-style="western"><surname>Chou</surname><given-names>R</given-names></name></person-group><article-title>CDC Clinical practice guideline for prescribing opioids for pain - United States, 2022</article-title><source>MMWR Recomm. Rep.</source><year>2022</year><volume>71</volume><issue>3</issue><fpage>1</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.15585/mmwr.rr7103a1</pub-id><pub-id pub-id-type="pmid">36327391</pub-id><pub-id pub-id-type="pmcid">PMC9639433</pub-id></element-citation><mixed-citation id="mc-CR5" publication-type="journal">Dowell, D., Ragan, K. R., Jones, C. M., Baldwin, G. T. &amp; Chou, R. CDC Clinical practice guideline for prescribing opioids for pain - United States, 2022. <italic toggle="yes">MMWR Recomm. Rep.</italic><bold>71</bold>(3), 1&#8211;95 (2022).<pub-id pub-id-type="pmid">36327391</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.15585/mmwr.rr7103a1</pub-id><pub-id pub-id-type="pmcid">PMC9639433</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alsultan</surname><given-names>MM</given-names></name><name name-style="western"><surname>Guo</surname><given-names>JJ</given-names></name></person-group><article-title>Utilization, spending, and price of opioid medications in the US Medicaid programs between 1991 and 2019</article-title><source>Am. Health Drug Benefits</source><year>2022</year><volume>15</volume><issue>1</issue><fpage>31</fpage><lpage>37</lpage><pub-id pub-id-type="pmid">35586617</pub-id><pub-id pub-id-type="pmcid">PMC9038001</pub-id></element-citation><mixed-citation id="mc-CR6" publication-type="journal">Alsultan, M. M. &amp; Guo, J. J. Utilization, spending, and price of opioid medications in the US Medicaid programs between 1991 and 2019. <italic toggle="yes">Am. Health Drug Benefits</italic><bold>15</bold>(1), 31&#8211;37 (2022).<pub-id pub-id-type="pmid">35586617</pub-id><pub-id pub-id-type="pmcid">PMC9038001</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jani</surname><given-names>M</given-names></name><name name-style="western"><surname>Birlie Yimer</surname><given-names>B</given-names></name><name name-style="western"><surname>Sheppard</surname><given-names>T</given-names></name><name name-style="western"><surname>Lunt</surname><given-names>M</given-names></name><name name-style="western"><surname>Dixon</surname><given-names>WG</given-names></name></person-group><article-title>Time trends and prescribing patterns of opioid drugs in UK primary care patients with non-cancer pain: A retrospective cohort study</article-title><source>PLoS Med.</source><year>2020</year><volume>17</volume><issue>10</issue><fpage>e1003270</fpage><pub-id pub-id-type="doi">10.1371/journal.pmed.1003270</pub-id><pub-id pub-id-type="pmid">33057368</pub-id><pub-id pub-id-type="pmcid">PMC7561110</pub-id></element-citation><mixed-citation id="mc-CR7" publication-type="journal">Jani, M., Birlie Yimer, B., Sheppard, T., Lunt, M. &amp; Dixon, W. G. Time trends and prescribing patterns of opioid drugs in UK primary care patients with non-cancer pain: A retrospective cohort study. <italic toggle="yes">PLoS Med.</italic><bold>17</bold>(10), e1003270 (2020).<pub-id pub-id-type="pmid">33057368</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pmed.1003270</pub-id><pub-id pub-id-type="pmcid">PMC7561110</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cho</surname><given-names>NR</given-names></name><name name-style="western"><surname>Chang</surname><given-names>YJ</given-names></name><name name-style="western"><surname>Lee</surname><given-names>D</given-names></name><name name-style="western"><surname>Kim</surname><given-names>JR</given-names></name><name name-style="western"><surname>Ko</surname><given-names>DS</given-names></name><name name-style="western"><surname>Choi</surname><given-names>JJ</given-names></name></person-group><article-title>Trends in opioid prescribing practices in South Korea, 2009&#8211;2019: Are we safe from an opioid epidemic?</article-title><source>PLoS ONE</source><year>2021</year><volume>16</volume><issue>5</issue><fpage>e0250972</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0250972</pub-id><pub-id pub-id-type="pmid">33979378</pub-id><pub-id pub-id-type="pmcid">PMC8115784</pub-id></element-citation><mixed-citation id="mc-CR8" publication-type="journal">Cho, N. R. et al. Trends in opioid prescribing practices in South Korea, 2009&#8211;2019: Are we safe from an opioid epidemic?. <italic toggle="yes">PLoS ONE</italic><bold>16</bold>(5), e0250972 (2021).<pub-id pub-id-type="pmid">33979378</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0250972</pub-id><pub-id pub-id-type="pmcid">PMC8115784</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Miotto</surname><given-names>K</given-names></name><name name-style="western"><surname>Cho</surname><given-names>AK</given-names></name><name name-style="western"><surname>Khalil</surname><given-names>MA</given-names></name><name name-style="western"><surname>Blanco</surname><given-names>K</given-names></name><name name-style="western"><surname>Sasaki</surname><given-names>JD</given-names></name><name name-style="western"><surname>Rawson</surname><given-names>R</given-names></name></person-group><article-title>Trends in tramadol: Pharmacology, metabolism, and misuse</article-title><source>Anesth. Analg.</source><year>2017</year><volume>124</volume><issue>1</issue><fpage>44</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1213/ANE.0000000000001683</pub-id><pub-id pub-id-type="pmid">27861439</pub-id></element-citation><mixed-citation id="mc-CR9" publication-type="journal">Miotto, K. et al. Trends in tramadol: Pharmacology, metabolism, and misuse. <italic toggle="yes">Anesth. Analg.</italic><bold>124</bold>(1), 44&#8211;51 (2017).<pub-id pub-id-type="pmid">27861439</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1213/ANE.0000000000001683</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mullins</surname><given-names>PM</given-names></name><name name-style="western"><surname>Mazer-Amirshahi</surname><given-names>M</given-names></name><name name-style="western"><surname>Pourmand</surname><given-names>A</given-names></name><name name-style="western"><surname>Perrone</surname><given-names>J</given-names></name><name name-style="western"><surname>Nelson</surname><given-names>LS</given-names></name><name name-style="western"><surname>Pines</surname><given-names>JM</given-names></name></person-group><article-title>Tramadol use in United States emergency departments 2007&#8211;2018</article-title><source>J. Emerg. Med.</source><year>2022</year><volume>62</volume><issue>5</issue><fpage>668</fpage><lpage>674</lpage><pub-id pub-id-type="doi">10.1016/j.jemermed.2022.01.004</pub-id><pub-id pub-id-type="pmid">35370038</pub-id></element-citation><mixed-citation id="mc-CR10" publication-type="journal">Mullins, P. M. et al. Tramadol use in United States emergency departments 2007&#8211;2018. <italic toggle="yes">J. Emerg. Med.</italic><bold>62</bold>(5), 668&#8211;674 (2022).<pub-id pub-id-type="pmid">35370038</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jemermed.2022.01.004</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>K</given-names></name><name name-style="western"><surname>Lee</surname><given-names>H</given-names></name><name name-style="western"><surname>Shin</surname><given-names>JY</given-names></name></person-group><article-title>Explosive increase in tramadol use in Korea 2003&#8211;2013: Analysis of patient trends based on the Korea national health insurance database</article-title><source>J. Psychoact. Drugs</source><year>2020</year><volume>52</volume><issue>2</issue><fpage>153</fpage><lpage>161</lpage><pub-id pub-id-type="doi">10.1080/02791072.2019.1612125</pub-id><pub-id pub-id-type="pmid">31079571</pub-id></element-citation><mixed-citation id="mc-CR11" publication-type="journal">Kim, K., Lee, H. &amp; Shin, J. Y. Explosive increase in tramadol use in Korea 2003&#8211;2013: Analysis of patient trends based on the Korea national health insurance database. <italic toggle="yes">J. Psychoact. Drugs</italic><bold>52</bold>(2), 153&#8211;161 (2020).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/02791072.2019.1612125</pub-id><pub-id pub-id-type="pmid">31079571</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Toupin April</surname><given-names>K</given-names></name><name name-style="western"><surname>Bisaillon</surname><given-names>J</given-names></name><name name-style="western"><surname>Welch</surname><given-names>V</given-names></name><etal/></person-group><article-title>Tramadol for osteoarthritis</article-title><source>Cochrane Database Syst. Rev.</source><year>2019</year><pub-id pub-id-type="doi">10.1002/14651858.CD005522.pub3</pub-id><pub-id pub-id-type="pmid">31132298</pub-id><pub-id pub-id-type="pmcid">PMC6536297</pub-id></element-citation><mixed-citation id="mc-CR12" publication-type="journal">Toupin April, K. <italic toggle="yes">et al.</italic> Tramadol for osteoarthritis. <italic toggle="yes">Cochrane Database Syst. Rev.</italic> (2019).<pub-id pub-id-type="pmid">31132298</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/14651858.CD005522.pub3</pub-id><pub-id pub-id-type="pmcid">PMC6536297</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wewege</surname><given-names>MA</given-names></name><name name-style="western"><surname>Bagg</surname><given-names>MK</given-names></name><name name-style="western"><surname>Jones</surname><given-names>MD</given-names></name><etal/></person-group><article-title>Comparative effectiveness and safety of analgesic medicines for adults with acute non-specific low back pain: systematic review and network meta-analysis</article-title><source>BMJ</source><year>2023</year><volume>380</volume><fpage>e072962</fpage><pub-id pub-id-type="pmid">36948512</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/bmj-2022-072962</pub-id><pub-id pub-id-type="pmcid">PMC10540836</pub-id></element-citation><mixed-citation id="mc-CR13" publication-type="journal">Wewege, M. A. et al. Comparative effectiveness and safety of analgesic medicines for adults with acute non-specific low back pain: systematic review and network meta-analysis. <italic toggle="yes">BMJ</italic><bold>380</bold>, e072962 (2023).<pub-id pub-id-type="pmid">36948512</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/bmj-2022-072962</pub-id><pub-id pub-id-type="pmcid">PMC10540836</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xie</surname><given-names>J</given-names></name><name name-style="western"><surname>Strauss</surname><given-names>VY</given-names></name><name name-style="western"><surname>Martinez-Laguna</surname><given-names>D</given-names></name><etal/></person-group><article-title>Association of tramadol vs codeine prescription dispensation with mortality and other adverse clinical outcomes</article-title><source>JAMA</source><year>2021</year><volume>326</volume><issue>15</issue><fpage>1504</fpage><lpage>1515</lpage><pub-id pub-id-type="doi">10.1001/jama.2021.15255</pub-id><pub-id pub-id-type="pmid">34665205</pub-id><pub-id pub-id-type="pmcid">PMC8527363</pub-id></element-citation><mixed-citation id="mc-CR14" publication-type="journal">Xie, J. et al. Association of tramadol vs codeine prescription dispensation with mortality and other adverse clinical outcomes. <italic toggle="yes">JAMA</italic><bold>326</bold>(15), 1504&#8211;1515 (2021).<pub-id pub-id-type="pmid">34665205</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jama.2021.15255</pub-id><pub-id pub-id-type="pmcid">PMC8527363</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Morrow</surname><given-names>RL</given-names></name><name name-style="western"><surname>Dormuth</surname><given-names>CR</given-names></name><name name-style="western"><surname>Paterson</surname><given-names>M</given-names></name><name name-style="western"><surname>Mamdani</surname><given-names>MM</given-names></name><name name-style="western"><surname>Gomes</surname><given-names>T</given-names></name><name name-style="western"><surname>Juurlink</surname><given-names>DN</given-names></name></person-group><article-title>Tramadol and the risk of seizure: nested case-control study of US patients with employer-sponsored health benefits</article-title><source>BMJ Open</source><year>2019</year><volume>9</volume><issue>3</issue><fpage>e026705</fpage><pub-id pub-id-type="doi">10.1136/bmjopen-2018-026705</pub-id><pub-id pub-id-type="pmid">30872555</pub-id><pub-id pub-id-type="pmcid">PMC6429854</pub-id></element-citation><mixed-citation id="mc-CR15" publication-type="journal">Morrow, R. L. et al. Tramadol and the risk of seizure: nested case-control study of US patients with employer-sponsored health benefits. <italic toggle="yes">BMJ Open</italic><bold>9</bold>(3), e026705 (2019).<pub-id pub-id-type="pmid">30872555</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/bmjopen-2018-026705</pub-id><pub-id pub-id-type="pmcid">PMC6429854</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fournier</surname><given-names>JP</given-names></name><name name-style="western"><surname>Azoulay</surname><given-names>L</given-names></name><name name-style="western"><surname>Yin</surname><given-names>H</given-names></name><name name-style="western"><surname>Montastruc</surname><given-names>JL</given-names></name><name name-style="western"><surname>Suissa</surname><given-names>S</given-names></name></person-group><article-title>Tramadol use and the risk of hospitalization for hypoglycemia in patients with noncancer pain</article-title><source>JAMA Intern. Med.</source><year>2015</year><volume>175</volume><issue>2</issue><fpage>186</fpage><lpage>193</lpage><pub-id pub-id-type="doi">10.1001/jamainternmed.2014.6512</pub-id><pub-id pub-id-type="pmid">25485799</pub-id></element-citation><mixed-citation id="mc-CR16" publication-type="journal">Fournier, J. P., Azoulay, L., Yin, H., Montastruc, J. L. &amp; Suissa, S. Tramadol use and the risk of hospitalization for hypoglycemia in patients with noncancer pain. <italic toggle="yes">JAMA Intern. Med.</italic><bold>175</bold>(2), 186&#8211;193 (2015).<pub-id pub-id-type="pmid">25485799</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jamainternmed.2014.6512</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wei</surname><given-names>J</given-names></name><name name-style="western"><surname>Wood</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Dubreuil</surname><given-names>M</given-names></name><etal/></person-group><article-title>Association of tramadol with risk of myocardial infarction among patients with osteoarthritis</article-title><source>Osteoarthr. Cartil.</source><year>2020</year><volume>28</volume><issue>2</issue><fpage>137</fpage><lpage>145</lpage><pub-id pub-id-type="doi">10.1016/j.joca.2019.10.001</pub-id><pub-id pub-id-type="pmcid">PMC7047659</pub-id><pub-id pub-id-type="pmid">31629022</pub-id></element-citation><mixed-citation id="mc-CR17" publication-type="journal">Wei, J. et al. Association of tramadol with risk of myocardial infarction among patients with osteoarthritis. <italic toggle="yes">Osteoarthr. Cartil.</italic><bold>28</bold>(2), 137&#8211;145 (2020).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.joca.2019.10.001</pub-id><pub-id pub-id-type="pmcid">PMC7047659</pub-id><pub-id pub-id-type="pmid">31629022</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hedenmalm</surname><given-names>K</given-names></name><name name-style="western"><surname>Slattery</surname><given-names>J</given-names></name><name name-style="western"><surname>Skibicka-Stepien</surname><given-names>I</given-names></name><etal/></person-group><article-title>Prescribing patterns of tramadol in adults in IMS&#174; primary care databases in France and Germany between 1 January 2006 and 30 June 2016</article-title><source>Eur. J. Clin. Pharmacol.</source><year>2019</year><volume>75</volume><fpage>707</fpage><lpage>716</lpage><pub-id pub-id-type="doi">10.1007/s00228-018-02622-9</pub-id><pub-id pub-id-type="pmid">30675632</pub-id></element-citation><mixed-citation id="mc-CR18" publication-type="journal">Hedenmalm, K. et al. Prescribing patterns of tramadol in adults in IMS&#174; primary care databases in France and Germany between 1 January 2006 and 30 June 2016. <italic toggle="yes">Eur. J. Clin. Pharmacol.</italic><bold>75</bold>, 707&#8211;716 (2019).<pub-id pub-id-type="pmid">30675632</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00228-018-02622-9</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Musich</surname><given-names>S</given-names></name><name name-style="western"><surname>Wang</surname><given-names>SS</given-names></name><name name-style="western"><surname>Schaeffer</surname><given-names>JA</given-names></name><name name-style="western"><surname>Slindee</surname><given-names>L</given-names></name><name name-style="western"><surname>Kraemer</surname><given-names>S</given-names></name><name name-style="western"><surname>Yeh</surname><given-names>CS</given-names></name></person-group><article-title>Safety events associated with tramadol use among older adults with osteoarthritis</article-title><source>Popul. Health Manag.</source><year>2021</year><volume>24</volume><issue>1</issue><fpage>122</fpage><lpage>132</lpage><pub-id pub-id-type="doi">10.1089/pop.2019.0220</pub-id><pub-id pub-id-type="pmid">32119805</pub-id><pub-id pub-id-type="pmcid">PMC7875128</pub-id></element-citation><mixed-citation id="mc-CR19" publication-type="journal">Musich, S. et al. Safety events associated with tramadol use among older adults with osteoarthritis. <italic toggle="yes">Popul. Health Manag.</italic><bold>24</bold>(1), 122&#8211;132 (2021).<pub-id pub-id-type="pmid">32119805</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1089/pop.2019.0220</pub-id><pub-id pub-id-type="pmcid">PMC7875128</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Neelamegam</surname><given-names>M</given-names></name><name name-style="western"><surname>Zgibor</surname><given-names>J</given-names></name><name name-style="western"><surname>Chen</surname><given-names>H</given-names></name><etal/></person-group><article-title>The effect of opioids on the cognitive function of older adults: results from the personality and total health through life study</article-title><source>Age Ageing</source><year>2021</year><volume>50</volume><issue>5</issue><fpage>1699</fpage><lpage>1708</lpage><pub-id pub-id-type="doi">10.1093/ageing/afab048</pub-id><pub-id pub-id-type="pmid">33755047</pub-id><pub-id pub-id-type="pmcid">PMC8437064</pub-id></element-citation><mixed-citation id="mc-CR20" publication-type="journal">Neelamegam, M. et al. The effect of opioids on the cognitive function of older adults: results from the personality and total health through life study. <italic toggle="yes">Age Ageing</italic><bold>50</bold>(5), 1699&#8211;1708 (2021).<pub-id pub-id-type="pmid">33755047</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/ageing/afab048</pub-id><pub-id pub-id-type="pmcid">PMC8437064</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dublin</surname><given-names>S</given-names></name><name name-style="western"><surname>Walker</surname><given-names>RL</given-names></name><name name-style="western"><surname>Gray</surname><given-names>SL</given-names></name><etal/></person-group><article-title>Prescription opioids and risk of dementia or cognitive decline: A prospective cohort study</article-title><source>J. Am. Geriatr. Soc.</source><year>2015</year><volume>63</volume><issue>8</issue><fpage>1519</fpage><lpage>1526</lpage><pub-id pub-id-type="doi">10.1111/jgs.13562</pub-id><pub-id pub-id-type="pmid">26289681</pub-id><pub-id pub-id-type="pmcid">PMC4776316</pub-id></element-citation><mixed-citation id="mc-CR21" publication-type="journal">Dublin, S. et al. Prescription opioids and risk of dementia or cognitive decline: A prospective cohort study. <italic toggle="yes">J. Am. Geriatr. Soc.</italic><bold>63</bold>(8), 1519&#8211;1526 (2015).<pub-id pub-id-type="pmid">26289681</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/jgs.13562</pub-id><pub-id pub-id-type="pmcid">PMC4776316</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Levine</surname><given-names>SZ</given-names></name><name name-style="western"><surname>Rotstein</surname><given-names>A</given-names></name><name name-style="western"><surname>Goldberg</surname><given-names>Y</given-names></name><name name-style="western"><surname>Reichenberg</surname><given-names>A</given-names></name><name name-style="western"><surname>Kodesh</surname><given-names>A</given-names></name></person-group><article-title>Opioid exposure and the risk of dementia: A national cohort study</article-title><source>Am. J. Geriatr. Psychiatry</source><year>2023</year><volume>31</volume><issue>5</issue><fpage>315</fpage><lpage>323</lpage><pub-id pub-id-type="doi">10.1016/j.jagp.2022.05.013</pub-id><pub-id pub-id-type="pmid">35718587</pub-id></element-citation><mixed-citation id="mc-CR22" publication-type="journal">Levine, S. Z., Rotstein, A., Goldberg, Y., Reichenberg, A. &amp; Kodesh, A. Opioid exposure and the risk of dementia: A national cohort study. <italic toggle="yes">Am. J. Geriatr. Psychiatry</italic><bold>31</bold>(5), 315&#8211;323 (2023).<pub-id pub-id-type="pmid">35718587</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jagp.2022.05.013</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sun</surname><given-names>M</given-names></name><name name-style="western"><surname>Chen</surname><given-names>WM</given-names></name><name name-style="western"><surname>Wu</surname><given-names>SY</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name></person-group><article-title>Long-term opioid use and dementia risk in patients with chronic pain</article-title><source>J. Am. Med. Dir. Assoc.</source><year>2023</year><volume>24</volume><issue>9</issue><fpage>1420</fpage><lpage>1426.e1422</lpage><pub-id pub-id-type="doi">10.1016/j.jamda.2023.06.035</pub-id><pub-id pub-id-type="pmid">37545051</pub-id></element-citation><mixed-citation id="mc-CR23" publication-type="journal">Sun, M., Chen, W. M., Wu, S. Y. &amp; Zhang, J. Long-term opioid use and dementia risk in patients with chronic pain. <italic toggle="yes">J. Am. Med. Dir. Assoc.</italic><bold>24</bold>(9), 1420-1426.e1422 (2023).<pub-id pub-id-type="pmid">37545051</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jamda.2023.06.035</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Raj</surname><given-names>K</given-names></name><name name-style="western"><surname>Chawla</surname><given-names>P</given-names></name><name name-style="western"><surname>Singh</surname><given-names>S</given-names></name></person-group><article-title>Neurobehavioral consequences associated with long term tramadol utilization and pathological mechanisms</article-title><source>CNS Neurol. Disord. Drug Targets</source><year>2019</year><volume>18</volume><issue>10</issue><fpage>758</fpage><lpage>768</lpage><pub-id pub-id-type="doi">10.2174/1871527318666191112124435</pub-id><pub-id pub-id-type="pmid">31721720</pub-id></element-citation><mixed-citation id="mc-CR24" publication-type="journal">Raj, K., Chawla, P. &amp; Singh, S. Neurobehavioral consequences associated with long term tramadol utilization and pathological mechanisms. <italic toggle="yes">CNS Neurol. Disord. Drug Targets</italic><bold>18</bold>(10), 758&#8211;768 (2019).<pub-id pub-id-type="pmid">31721720</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2174/1871527318666191112124435</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hosseini-Sharifabad</surname><given-names>A</given-names></name><name name-style="western"><surname>Rabbani</surname><given-names>M</given-names></name><name name-style="western"><surname>Sharifzadeh</surname><given-names>M</given-names></name><name name-style="western"><surname>Bagheri</surname><given-names>N</given-names></name></person-group><article-title>Acute and chronic tramadol administration impair spatial memory in rat</article-title><source>Res. Pharm. Sci.</source><year>2016</year><volume>11</volume><issue>1</issue><fpage>49</fpage><lpage>57</lpage><pub-id pub-id-type="pmid">27051432</pub-id><pub-id pub-id-type="pmcid">PMC4794937</pub-id></element-citation><mixed-citation id="mc-CR25" publication-type="journal">Hosseini-Sharifabad, A., Rabbani, M., Sharifzadeh, M. &amp; Bagheri, N. Acute and chronic tramadol administration impair spatial memory in rat. <italic toggle="yes">Res. Pharm. Sci.</italic><bold>11</bold>(1), 49&#8211;57 (2016).<pub-id pub-id-type="pmid">27051432</pub-id><pub-id pub-id-type="pmcid">PMC4794937</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR26"><label>26.</label><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Khatmi</surname><given-names>A</given-names></name><name name-style="western"><surname>Eskandarian Boroujeni</surname><given-names>M</given-names></name><name name-style="western"><surname>Ezi</surname><given-names>S</given-names></name><etal/></person-group><article-title>Combined molecular, structural and memory data unravel the destructive effect of tramadol on hippocampus</article-title><source>Neurosci Lett.</source><year>2022</year><volume>771</volume><fpage>136418</fpage><pub-id pub-id-type="doi">10.1016/j.neulet.2021.136418</pub-id><pub-id pub-id-type="pmid">34954113</pub-id></element-citation><mixed-citation id="mc-CR26" publication-type="journal">Khatmi, A. et al. Combined molecular, structural and memory data unravel the destructive effect of tramadol on hippocampus. <italic toggle="yes">Neurosci. Lett.</italic><bold>771</bold>, 136418 (2022).<pub-id pub-id-type="pmid">34954113</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.neulet.2021.136418</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR27"><label>27.</label><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hussein</surname><given-names>OA</given-names></name><name name-style="western"><surname>Abdel Mola</surname><given-names>AF</given-names></name><name name-style="western"><surname>Rateb</surname><given-names>A</given-names></name></person-group><article-title>Tramadol administration induced hippocampal cells apoptosis, astrogliosis, and microgliosis in juvenile and adult male mice, histological and immunohistochemical study</article-title><source>Ultrastruct. Pathol.</source><year>2020</year><volume>44</volume><issue>1</issue><fpage>81</fpage><lpage>102</lpage><pub-id pub-id-type="doi">10.1080/01913123.2019.1711480</pub-id><pub-id pub-id-type="pmid">31924115</pub-id></element-citation><mixed-citation id="mc-CR27" publication-type="journal">Hussein, O. A., Abdel Mola, A. F. &amp; Rateb, A. Tramadol administration induced hippocampal cells apoptosis, astrogliosis, and microgliosis in juvenile and adult male mice, histological and immunohistochemical study. <italic toggle="yes">Ultrastruct. Pathol.</italic><bold>44</bold>(1), 81&#8211;102 (2020).<pub-id pub-id-type="pmid">31924115</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/01913123.2019.1711480</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR28"><label>28.</label><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Taipale</surname><given-names>H</given-names></name><name name-style="western"><surname>Hamina</surname><given-names>A</given-names></name><name name-style="western"><surname>Lampela</surname><given-names>P</given-names></name><etal/></person-group><article-title>Is Alzheimer&#8217;s disease associated with previous opioid use?</article-title><source>Pain Med.</source><year>2018</year><volume>19</volume><issue>11</issue><fpage>2115</fpage><lpage>2121</lpage><pub-id pub-id-type="doi">10.1093/pm/pnx210</pub-id><pub-id pub-id-type="pmid">29025166</pub-id></element-citation><mixed-citation id="mc-CR28" publication-type="journal">Taipale, H. et al. Is Alzheimer&#8217;s disease associated with previous opioid use?. <italic toggle="yes">Pain Med.</italic><bold>19</bold>(11), 2115&#8211;2121 (2018).<pub-id pub-id-type="pmid">29025166</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/pm/pnx210</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR29"><label>29.</label><citation-alternatives><element-citation id="ec-CR29" publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Anekar</surname><given-names>AA</given-names></name><name name-style="western"><surname>Hendrix</surname><given-names>JM</given-names></name><name name-style="western"><surname>Cascella</surname><given-names>M</given-names></name></person-group><person-group person-group-type="editor"><name name-style="western"><surname>Anekar</surname><given-names>AA</given-names></name><name name-style="western"><surname>Hendrix</surname><given-names>JM</given-names></name><name name-style="western"><surname>Cascella</surname><given-names>M</given-names></name></person-group><article-title>WHO analgesic ladder</article-title><source>StatPearls</source><year>2023</year><publisher-name>StatPearls Publishing</publisher-name><pub-id pub-id-type="pmid">32119322</pub-id></element-citation><mixed-citation id="mc-CR29" publication-type="book">Anekar, A. A., Hendrix, J. M. &amp; Cascella, M. WHO analgesic ladder. In <italic toggle="yes">StatPearls</italic> (eds Anekar, A. A. et al.) (StatPearls Publishing, 2023).<pub-id pub-id-type="pmid">32119322</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR30"><label>30.</label><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kostev</surname><given-names>K</given-names></name><name name-style="western"><surname>Bohlken</surname><given-names>J</given-names></name><name name-style="western"><surname>Jacob</surname><given-names>L</given-names></name></person-group><article-title>Analysis of the effects of selective serotonin (and noradrenaline) reuptake inhibitors on the risk of dementia in patients with depression</article-title><source>J. Alzheimers Dis.</source><year>2019</year><volume>69</volume><issue>2</issue><fpage>577</fpage><lpage>583</lpage><pub-id pub-id-type="doi">10.3233/JAD-190239</pub-id><pub-id pub-id-type="pmid">31104029</pub-id></element-citation><mixed-citation id="mc-CR30" publication-type="journal">Kostev, K., Bohlken, J. &amp; Jacob, L. Analysis of the effects of selective serotonin (and noradrenaline) reuptake inhibitors on the risk of dementia in patients with depression. <italic toggle="yes">J. Alzheimers Dis.</italic><bold>69</bold>(2), 577&#8211;583 (2019).<pub-id pub-id-type="pmid">31104029</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3233/JAD-190239</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR31"><label>31.</label><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>GH</given-names></name><name name-style="western"><surname>Chen</surname><given-names>WH</given-names></name><name name-style="western"><surname>Chang</surname><given-names>SH</given-names></name><etal/></person-group><article-title>Association between first-line antidepressant use and risk of dementia in older adults: a retrospective cohort study</article-title><source>BMC Geriatr.</source><year>2023</year><volume>23</volume><fpage>825</fpage><pub-id pub-id-type="doi">10.1186/s12877-023-04475-z</pub-id><pub-id pub-id-type="pmid">38066473</pub-id><pub-id pub-id-type="pmcid">PMC10709864</pub-id></element-citation><mixed-citation id="mc-CR31" publication-type="journal">Wang, G. H. et al. Association between first-line antidepressant use and risk of dementia in older adults: a retrospective cohort study. <italic toggle="yes">BMC Geriatr.</italic><bold>23</bold>, 825 (2023).<pub-id pub-id-type="pmid">38066473</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12877-023-04475-z</pub-id><pub-id pub-id-type="pmcid">PMC10709864</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR32"><label>32.</label><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Livingston</surname><given-names>G</given-names></name><name name-style="western"><surname>Huntley</surname><given-names>J</given-names></name><name name-style="western"><surname>Sommerlad</surname><given-names>A</given-names></name><etal/></person-group><article-title>Dementia prevention, intervention, and care: 2020 report of the lancet commission</article-title><source>Lancet</source><year>2020</year><volume>396</volume><fpage>413</fpage><lpage>446</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(20)30367-6</pub-id><pub-id pub-id-type="pmid">32738937</pub-id><pub-id pub-id-type="pmcid">PMC7392084</pub-id></element-citation><mixed-citation id="mc-CR32" publication-type="journal">Livingston, G. et al. Dementia prevention, intervention, and care: 2020 report of the lancet commission. <italic toggle="yes">Lancet</italic><bold>396</bold>, 413&#8211;446 (2020).<pub-id pub-id-type="pmid">32738937</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S0140-6736(20)30367-6</pub-id><pub-id pub-id-type="pmcid">PMC7392084</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR33"><label>33.</label><citation-alternatives><element-citation id="ec-CR33" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aghajanpour</surname><given-names>F</given-names></name><name name-style="western"><surname>Boroujeni</surname><given-names>ME</given-names></name><name name-style="western"><surname>Jahanian</surname><given-names>A</given-names></name><etal/></person-group><article-title>Tramadol: a potential neurotoxic agent affecting prefrontal cortices in adult male rats and PC-12 cell line</article-title><source>Neurotox Res.</source><year>2020</year><volume>38</volume><issue>2</issue><fpage>385</fpage><lpage>397</lpage><pub-id pub-id-type="doi">10.1007/s12640-020-00214-z</pub-id><pub-id pub-id-type="pmid">32378056</pub-id></element-citation><mixed-citation id="mc-CR33" publication-type="journal">Aghajanpour, F. et al. Tramadol: a potential neurotoxic agent affecting prefrontal cortices in adult male rats and PC-12 cell line. <italic toggle="yes">Neurotox. Res.</italic><bold>38</bold>(2), 385&#8211;397 (2020).<pub-id pub-id-type="pmid">32378056</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s12640-020-00214-z</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR34"><label>34.</label><citation-alternatives><element-citation id="ec-CR34" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ezi</surname><given-names>S</given-names></name><name name-style="western"><surname>Boroujeni</surname><given-names>ME</given-names></name><name name-style="western"><surname>Khatmi</surname><given-names>A</given-names></name><etal/></person-group><article-title>Chronic exposure to tramadol induces neurodegeneration in the cerebellum of adult male rats</article-title><source>Neurotox Res.</source><year>2021</year><volume>39</volume><fpage>1134</fpage><lpage>1147</lpage><pub-id pub-id-type="doi">10.1007/s12640-021-00354-w</pub-id><pub-id pub-id-type="pmid">33818692</pub-id></element-citation><mixed-citation id="mc-CR34" publication-type="journal">Ezi, S. <italic toggle="yes">et al.</italic> Chronic exposure to tramadol induces neurodegeneration in the cerebellum of adult male rats. <italic toggle="yes">Neurotox. Res.</italic><bold>39</bold>, 1134&#8211;1147 (2021).<pub-id pub-id-type="pmid">33818692</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s12640-021-00354-w</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR35"><label>35.</label><citation-alternatives><element-citation id="ec-CR35" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Soltani</surname><given-names>R</given-names></name><name name-style="western"><surname>Boroujeni</surname><given-names>ME</given-names></name><name name-style="western"><surname>Aghajanpour</surname><given-names>F</given-names></name><etal/></person-group><article-title>Tramadol exposure upregulated apoptosis, inflammation and autophagy in PC12 cells and rat&#8217;s striatum: An in vitro- in vivo approach</article-title><source>J. Chem. Neuroanat.</source><year>2020</year><volume>109</volume><fpage>101820</fpage><pub-id pub-id-type="doi">10.1016/j.jchemneu.2020.101820</pub-id><pub-id pub-id-type="pmid">32526246</pub-id></element-citation><mixed-citation id="mc-CR35" publication-type="journal">Soltani, R. et al. Tramadol exposure upregulated apoptosis, inflammation and autophagy in PC12 cells and rat&#8217;s striatum: An in vitro- in vivo approach. <italic toggle="yes">J. Chem. Neuroanat.</italic><bold>109</bold>, 101820 (2020).<pub-id pub-id-type="pmid">32526246</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jchemneu.2020.101820</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR36"><label>36.</label><citation-alternatives><element-citation id="ec-CR36" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Swart</surname><given-names>LM</given-names></name><name name-style="western"><surname>van der Zanden</surname><given-names>V</given-names></name><name name-style="western"><surname>Spies</surname><given-names>PE</given-names></name><name name-style="western"><surname>de Rooij</surname><given-names>SE</given-names></name><name name-style="western"><surname>van Munster</surname><given-names>BC</given-names></name></person-group><article-title>The comparative risk of delirium with different opioids: A systematic review</article-title><source>Drugs Aging</source><year>2017</year><volume>34</volume><issue>6</issue><fpage>437</fpage><lpage>443</lpage><pub-id pub-id-type="doi">10.1007/s40266-017-0455-9</pub-id><pub-id pub-id-type="pmid">28405945</pub-id><pub-id pub-id-type="pmcid">PMC5427092</pub-id></element-citation><mixed-citation id="mc-CR36" publication-type="journal">Swart, L. M., van der Zanden, V., Spies, P. E., de Rooij, S. E. &amp; van Munster, B. C. The comparative risk of delirium with different opioids: A systematic review. <italic toggle="yes">Drugs Aging</italic><bold>34</bold>(6), 437&#8211;443 (2017).<pub-id pub-id-type="pmid">28405945</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s40266-017-0455-9</pub-id><pub-id pub-id-type="pmcid">PMC5427092</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR37"><label>37.</label><citation-alternatives><element-citation id="ec-CR37" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brouquet</surname><given-names>A</given-names></name><name name-style="western"><surname>Cudennec</surname><given-names>T</given-names></name><name name-style="western"><surname>Benoist</surname><given-names>S</given-names></name><etal/></person-group><article-title>Impaired mobility, ASA status and administration of tramadol are risk factors for postoperative delirium in patients aged 75 years or more after major abdominal surgery</article-title><source>Ann. Surg.</source><year>2010</year><volume>251</volume><issue>4</issue><fpage>759</fpage><lpage>765</lpage><pub-id pub-id-type="doi">10.1097/SLA.0b013e3181c1cfc9</pub-id><pub-id pub-id-type="pmid">20224380</pub-id></element-citation><mixed-citation id="mc-CR37" publication-type="journal">Brouquet, A. et al. Impaired mobility, ASA status and administration of tramadol are risk factors for postoperative delirium in patients aged 75 years or more after major abdominal surgery. <italic toggle="yes">Ann. Surg.</italic><bold>251</bold>(4), 759&#8211;765 (2010).<pub-id pub-id-type="pmid">20224380</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/SLA.0b013e3181c1cfc9</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR38"><label>38.</label><citation-alternatives><element-citation id="ec-CR38" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fong</surname><given-names>TG</given-names></name><name name-style="western"><surname>Inouye</surname><given-names>SK</given-names></name></person-group><article-title>The inter-relationship between delirium and dementia: the importance of delirium prevention</article-title><source>Nat. Rev. Neurol.</source><year>2022</year><volume>18</volume><issue>10</issue><fpage>579</fpage><lpage>596</lpage><pub-id pub-id-type="doi">10.1038/s41582-022-00698-7</pub-id><pub-id pub-id-type="pmid">36028563</pub-id><pub-id pub-id-type="pmcid">PMC9415264</pub-id></element-citation><mixed-citation id="mc-CR38" publication-type="journal">Fong, T. G. &amp; Inouye, S. K. The inter-relationship between delirium and dementia: the importance of delirium prevention. <italic toggle="yes">Nat. Rev. Neurol.</italic><bold>18</bold>(10), 579&#8211;596 (2022).<pub-id pub-id-type="pmid">36028563</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41582-022-00698-7</pub-id><pub-id pub-id-type="pmcid">PMC9415264</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR39"><label>39.</label><citation-alternatives><element-citation id="ec-CR39" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gibbison</surname><given-names>B</given-names></name><name name-style="western"><surname>Bailey</surname><given-names>CR</given-names></name><name name-style="western"><surname>Klein</surname><given-names>AA</given-names></name></person-group><article-title>Tramadol - the marmite(&#8482;) drug</article-title><source>Anaesthesia</source><year>2015</year><volume>70</volume><issue>2</issue><fpage>125</fpage><lpage>130</lpage><pub-id pub-id-type="doi">10.1111/anae.12972</pub-id><pub-id pub-id-type="pmid">25491015</pub-id></element-citation><mixed-citation id="mc-CR39" publication-type="journal">Gibbison, B., Bailey, C. R. &amp; Klein, A. A. Tramadol - the marmite(&#8482;) drug. <italic toggle="yes">Anaesthesia</italic><bold>70</bold>(2), 125&#8211;130 (2015).<pub-id pub-id-type="pmid">25491015</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/anae.12972</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR40"><label>40.</label><citation-alternatives><element-citation id="ec-CR40" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Iadecola</surname><given-names>C</given-names></name><name name-style="western"><surname>Smith</surname><given-names>EE</given-names></name><name name-style="western"><surname>Anrather</surname><given-names>J</given-names></name><etal/></person-group><article-title>The neurovasculome: Key roles in brain health and cognitive impairment: A scientific statement from the American heart association/American stroke association</article-title><source>Stroke</source><year>2023</year><volume>54</volume><issue>6</issue><fpage>e251</fpage><lpage>e271</lpage><pub-id pub-id-type="doi">10.1161/STR.0000000000000431</pub-id><pub-id pub-id-type="pmid">37009740</pub-id><pub-id pub-id-type="pmcid">PMC10228567</pub-id></element-citation><mixed-citation id="mc-CR40" publication-type="journal">Iadecola, C. et al. The neurovasculome: Key roles in brain health and cognitive impairment: A scientific statement from the American heart association/American stroke association. <italic toggle="yes">Stroke</italic><bold>54</bold>(6), e251&#8211;e271 (2023).<pub-id pub-id-type="pmid">37009740</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/STR.0000000000000431</pub-id><pub-id pub-id-type="pmcid">PMC10228567</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR41"><label>41.</label><citation-alternatives><element-citation id="ec-CR41" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Whitlock</surname><given-names>EL</given-names></name><name name-style="western"><surname>Diaz-Ramirez</surname><given-names>LG</given-names></name><name name-style="western"><surname>Glymour</surname><given-names>MM</given-names></name><name name-style="western"><surname>Boscardin</surname><given-names>WJ</given-names></name><name name-style="western"><surname>Covinsky</surname><given-names>KE</given-names></name><name name-style="western"><surname>Smith</surname><given-names>AK</given-names></name></person-group><article-title>Association between persistent pain and memory decline and dementia in a longitudinal cohort of elders</article-title><source>JAMA Intern. Med.</source><year>2017</year><volume>177</volume><issue>8</issue><fpage>1146</fpage><lpage>1153</lpage><pub-id pub-id-type="doi">10.1001/jamainternmed.2017.1622</pub-id><pub-id pub-id-type="pmid">28586818</pub-id><pub-id pub-id-type="pmcid">PMC5588896</pub-id></element-citation><mixed-citation id="mc-CR41" publication-type="journal">Whitlock, E. L. et al. Association between persistent pain and memory decline and dementia in a longitudinal cohort of elders. <italic toggle="yes">JAMA Intern. Med.</italic><bold>177</bold>(8), 1146&#8211;1153 (2017).<pub-id pub-id-type="pmid">28586818</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jamainternmed.2017.1622</pub-id><pub-id pub-id-type="pmcid">PMC5588896</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR42"><label>42.</label><citation-alternatives><element-citation id="ec-CR42" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rouch</surname><given-names>I</given-names></name><name name-style="western"><surname>Edjolo</surname><given-names>A</given-names></name><name name-style="western"><surname>Laurent</surname><given-names>B</given-names></name><name name-style="western"><surname>Dartigues</surname><given-names>JF</given-names></name><name name-style="western"><surname>Amieva</surname><given-names>H</given-names></name></person-group><article-title>Chronic pain and long-term dementia risk in older adults: Results from a 24-year longitudinal study</article-title><source>Int. J. Geriatr. Psychiatry</source><year>2022</year><pub-id pub-id-type="doi">10.1002/gps.5713</pub-id><pub-id pub-id-type="pmid">35434855</pub-id></element-citation><mixed-citation id="mc-CR42" publication-type="journal">Rouch, I., Edjolo, A., Laurent, B., Dartigues, J. F. &amp; Amieva, H. Chronic pain and long-term dementia risk in older adults: Results from a 24-year longitudinal study. <italic toggle="yes">Int. J. Geriatr. Psychiatry</italic>&#160;(2022).<pub-id pub-id-type="pmid">35434855</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/gps.5713</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR43"><label>43.</label><citation-alternatives><element-citation id="ec-CR43" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>HK</given-names></name><name name-style="western"><surname>Song</surname><given-names>SO</given-names></name><name name-style="western"><surname>Noh</surname><given-names>J</given-names></name><name name-style="western"><surname>Jeong</surname><given-names>IK</given-names></name><name name-style="western"><surname>Lee</surname><given-names>BW</given-names></name></person-group><article-title>Data configuration and publication trends for the Korean national health insurance and health insurance review &amp; assessment database</article-title><source>Diabetes Metab. J.</source><year>2020</year><volume>44</volume><issue>5</issue><fpage>671</fpage><lpage>678</lpage><pub-id pub-id-type="doi">10.4093/dmj.2020.0207</pub-id><pub-id pub-id-type="pmid">33115211</pub-id><pub-id pub-id-type="pmcid">PMC7643590</pub-id></element-citation><mixed-citation id="mc-CR43" publication-type="journal">Kim, H. K., Song, S. O., Noh, J., Jeong, I. K. &amp; Lee, B. W. Data configuration and publication trends for the Korean national health insurance and health insurance review &amp; assessment database. <italic toggle="yes">Diabetes Metab. J.</italic><bold>44</bold>(5), 671&#8211;678 (2020).<pub-id pub-id-type="pmid">33115211</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.4093/dmj.2020.0207</pub-id><pub-id pub-id-type="pmcid">PMC7643590</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR44"><label>44.</label><citation-alternatives><element-citation id="ec-CR44" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Seong</surname><given-names>SC</given-names></name><name name-style="western"><surname>Kim</surname><given-names>YY</given-names></name><name name-style="western"><surname>Park</surname><given-names>SK</given-names></name><etal/></person-group><article-title>Cohort profile: the national health insurance service-national health screening cohort (NHIS-HEALS) in Korea</article-title><source>BMJ Open</source><year>2017</year><volume>7</volume><issue>9</issue><fpage>e016640</fpage><pub-id pub-id-type="doi">10.1136/bmjopen-2017-016640</pub-id><pub-id pub-id-type="pmid">28947447</pub-id><pub-id pub-id-type="pmcid">PMC5623538</pub-id></element-citation><mixed-citation id="mc-CR44" publication-type="journal">Seong, S. C. et al. Cohort profile: the national health insurance service-national health screening cohort (NHIS-HEALS) in Korea. <italic toggle="yes">BMJ Open</italic><bold>7</bold>(9), e016640 (2017).<pub-id pub-id-type="pmid">28947447</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/bmjopen-2017-016640</pub-id><pub-id pub-id-type="pmcid">PMC5623538</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR45"><label>45.</label><citation-alternatives><element-citation id="ec-CR45" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Austin</surname><given-names>PC</given-names></name></person-group><article-title>Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies</article-title><source>Pharm. Stat.</source><year>2011</year><volume>10</volume><issue>2</issue><fpage>150</fpage><lpage>161</lpage><pub-id pub-id-type="doi">10.1002/pst.433</pub-id><pub-id pub-id-type="pmid">20925139</pub-id><pub-id pub-id-type="pmcid">PMC3120982</pub-id></element-citation><mixed-citation id="mc-CR45" publication-type="journal">Austin, P. C. Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies. <italic toggle="yes">Pharm. Stat.</italic><bold>10</bold>(2), 150&#8211;161 (2011).<pub-id pub-id-type="pmid">20925139</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/pst.433</pub-id><pub-id pub-id-type="pmcid">PMC3120982</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR46"><label>46.</label><citation-alternatives><element-citation id="ec-CR46" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jeong</surname><given-names>SM</given-names></name><name name-style="western"><surname>Shin</surname><given-names>DW</given-names></name><name name-style="western"><surname>Lee</surname><given-names>JE</given-names></name><etal/></person-group><article-title>Anemia is associated with incidence of dementia: a national health screening study in Korea involving 37,900 persons</article-title><source>Alzheimers Res. Ther.</source><year>2017</year><volume>9</volume><fpage>94</fpage><pub-id pub-id-type="doi">10.1186/s13195-017-0322-2</pub-id><pub-id pub-id-type="pmid">29212527</pub-id><pub-id pub-id-type="pmcid">PMC5719530</pub-id></element-citation><mixed-citation id="mc-CR46" publication-type="journal">Jeong, S. M. et al. Anemia is associated with incidence of dementia: a national health screening study in Korea involving 37,900 persons. <italic toggle="yes">Alzheimers Res. Ther.</italic><bold>9</bold>, 94 (2017).<pub-id pub-id-type="pmid">29212527</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s13195-017-0322-2</pub-id><pub-id pub-id-type="pmcid">PMC5719530</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR47"><label>47.</label><citation-alternatives><element-citation id="ec-CR47" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fine</surname><given-names>JP</given-names></name><name name-style="western"><surname>Gray</surname><given-names>RJ</given-names></name></person-group><article-title>A proportional hazards model for the subdistribution of a competing risk</article-title><source>J. Am. Stat. Assoc.</source><year>1999</year><volume>94</volume><issue>446</issue><fpage>496</fpage><lpage>509</lpage><pub-id pub-id-type="doi">10.1080/01621459.1999.10474144</pub-id></element-citation><mixed-citation id="mc-CR47" publication-type="journal">Fine, J. P. &amp; Gray, R. J. A proportional hazards model for the subdistribution of a competing risk. <italic toggle="yes">J. Am. Stat. Assoc.</italic><bold>94</bold>(446), 496&#8211;509 (1999).</mixed-citation></citation-alternatives></ref><ref id="CR48"><label>48.</label><mixed-citation publication-type="other">Delgado-Rodr&#237;guez M, Llorca J. Bias.<italic toggle="yes"> J. Epidemiol. Community Health</italic><bold>58</bold>(8), 635&#8211;641. (2004)<pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/jech.2003.008466</pub-id><pub-id pub-id-type="pmcid">PMC1732856</pub-id><pub-id pub-id-type="pmid">15252064</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>